Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls
Open accessAbstract
Polycystic ovary syndrome (PCOS) is a heterogeneous disorder characterized by hyperandrogenism and chronic anovulation. Depending on diagnostic criteria, 6% to 20% of reproductive aged women are affected. Symptoms of PCOS arise during the early pubertal years. Both normal female pubertal development and PCOS are characterized by irregular menstrual cycles, anovulation, and acne. Owing to the complicated interwoven pathophysiology, discerning the inciting causes is challenging. Most available clinical data communicate findings and outcomes in adult women. Whereas the Rotterdam criteria are accepted for adult women, different diagnostic criteria for PCOS in adolescent girls have been delineated. Diagnostic features for adolescent girls are menstrual irregularity, clinical hyperandrogenism, and/or hyperandrogenemia. Pelvic ultrasound findings are not needed for the diagnosis of PCOS in adolescent girls. Even before definitive diagnosis of PCOS, adolescents with clinical signs of androgen excess and oligomenorrhea/amenorrhea, features of PCOS, can be regarded as being “at risk for PCOS.” Management of both those at risk for PCOS and those with a confirmed PCOS diagnosis includes education, healthy lifestyle interventions, and therapeutic interventions targeting their symptoms. Interventions can include metformin, combined oral contraceptive pills, spironolactone, and local treatments for hirsutism and acne. In addition to ascertaining for associated comorbidities, management should also include regular follow-up visits and planned transition to adult care providers. Comprehensive knowledge regarding the pathogenesis of PCOS will enable earlier identification of girls with high propensity to develop PCOS. Timely implementation of individualized therapeutic interventions will improve overall management of PCOS during adolescence, prevent associated comorbidities, and improve quality of life.
AI snapshot
Written from the paper’s full text.
TL;DR
Polycystic ovary syndrome (PCOS) is a heterogeneous disorder of hyperandrogenism and chronic anovulation affecting ∼6% to 20% of reproductive-aged women, with features often emerging in early puberty. This narrative review emphasizes adolescent-specific diagnosis and management, including lifestyle, metformin, combined oral contraceptives, antiandrogens, and local hirsutism/acne treatments.
Key findings
- PCOS affects ∼6% to 20% of reproductive-aged women depending on diagnostic criteria; it is characterized by hyperandrogenism and chronic anovulation, with symptoms arising during the early pubertal years.
- For adolescent girls, diagnostic features are menstrual irregularity, clinical hyperandrogenism, and/or hyperandrogenemia; pelvic ultrasound findings are not needed for diagnosis, and girls with features but without persistent oligomenorrhea can be considered “at risk for PCOS.”
- Management includes education, healthy lifestyle interventions, metformin, combined oral contraceptive pills (COCPs), spironolactone, and local treatments for hirsutism and acne; metformin doses ranged from 1000 to 2000 mg daily, and the lowest effective COCP estrogen dose (20 to 30 µg ethinylestradiol) should be considered.
- Weight loss strategies up to 7% of body weight improved menstrual irregularity and testosterone levels; heritability is ∼70%, and GWASs have identified at least 16 susceptibility loci for PCOS.
Methods
- Narrative review synthesizing clinical, experimental, and genetic data, with emphasis on adolescent girls; it is not a systematic review or meta-analysis.
- Evidence includes adult clinical studies, preclinical animal and in vitro models, GWASs, and international guidelines; the paper notes that most relevant clinical data come from adult women and referral-based severe phenotypes.
- Main analysis is qualitative synthesis of pathophysiology, diagnosis, and treatment, citing meta-analyses and randomized controlled trials where available.
Limitations
- The paper states that most clinical data communicate findings in adult women, referral bias focuses on more severe phenotypes, adolescent-specific data are limited, and some cited studies have small sample sizes; no microbiome data for adolescents are available.
- The paper states that diagnosing PCOS in adolescent girls is problematic because irregular menses, acne, mild hyperandrogenism, and multifollicular ovarian morphology overlap with normal puberty, and pelvic ultrasound is unnecessary/inconsistent in adolescents.
- Evident from the text: as a narrative review, it does not report a systematic search strategy or formal quality appraisal, and many treatment recommendations are extrapolated from adult women or small/short adolescent trials (e.g., metformin RCTs mostly 6 months, only one 24 months, with no longer-term studies).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 173 cited sources checked · 0 supported · 0 flagged
- Premisecitation
The concentrations of 11-oxygenated steroids are higher in women with PCOS than among healthy premenopausal women.
“The concentrations of these 11-oxygenated steroids were reported to be higher in women with PCOS than among healthy premenopausal women [34].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] O’Reilly, 2017, 11-Oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome, J Clin Endocrinol Metab source
Not checked in the free run.
- Premisecitation
Symptoms of PCOS arise during the early pubertal years.
“Symptoms of PCOS arise during the early pubertal years.”
- Also stated in: § 1. Pathophysiology · plain
“PCOS develops during the early pubertal years [6].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] Apter, 1994, Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome, J Clin Endocrinol Metab
Not checked in the free run.
- Also stated in: § 1. Pathophysiology · plain
- Premisecitation
Available data document constitutively increased androgen production and CYP17A1 expression in cultured theca cells isolated from PCOS ovaries.
“Available data document constitutively increased androgen production and CYP17A1 expression in cultured theca cells isolated from PCOS ovaries [24–26].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [24] Gilling-Smith, 1994, Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries, J Clin Endocrinol Metab
Not checked in the free run.
- cites [25] Gilling-Smith, 1997, Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome, Clin Endocrinol (Oxf) source
Not checked in the free run.
- cites [26] Nelson, 1999, Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries, Mol Endocrinol source
Not checked in the free run.
- Premisecitation
Aberrant development during the earliest stages of follicular growth likely contributes to the ovarian aspects of PCOS.
“Aberrant development during these earliest stages of follicular growth likely contributes to the ovarian aspects of PCOS [19].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] Franks, 2018, Androgen action in the ovary, Front Endocrinol (Lausanne) source
Not checked in the free run.
- Premisecitation
Most relevant information on PCOS has been accrued through clinical studies involving adult women in which referral bias focuses on investigation of the more severe phenotypes.
“However, most relevant information has been accrued through clinical studies involving adult women in which referral bias focuses on investigation of the more severe phenotypes [7].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] Lizneva, 2016, Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis, Fertil Steril source
Not checked in the free run.
- Premisecitation
Overexpression of the alternative spliced variant DENND1A.V2 recapitulated a PCOS phenotype in cultured theca cells obtained from normal women, indicating a role for this variant in excessive theca cell androgen production.
“Overexpression of the alternative spliced variant, DENND1A.V2, of this gene recapitulated a PCOS phenotype in cultured theca cells obtained from normal women, indicating a role for this variant in the excessive theca cell androgen production [27].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27] McAllister, 2014, Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype, Proc Natl Acad Sci USA source
Not checked in the free run.
- Premisecitation
Women with PCOS have intrinsic insulin resistance independent of the extent of obesity and magnitude of androgen concentrations.
“Women with PCOS have intrinsic IR independent of the extent of obesity and magnitude of androgen concentrations [68].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [68] Dunaif, 1989, Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome, Diabetes source
Not checked in the free run.
- Premisecitation
PCOS reflects interactions among multiple proteins and genes influenced by epigenetic and environmental factors.
“PCOS reflects the interactions among multiple proteins and genes influenced by epigenetic and environmental factors (Fig. 1) [5].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Mohamed-Hussein, 2009, Construction of a polycystic ovarian syndrome (PCOS) pathway based on the interactions of PCOS-related proteins retrieved from bibliomic data, Theor Biol Med Model source
Not checked in the free run.
- Premisecitation
In a nonhuman primate model of early gestational androgen exposure, transient pancreatic dysfunction manifested by hypoglycemia, an increased number of β-cells, small islets, and relative hyperinsulinemia has been observed.
“Curiously, transient pancreatic dysfunction manifested by hypoglycemia, an increased number of β-cells, small islets, and relative hyperinsulinemia have been observed in this NHP model of early gestational androgen exposure [80].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [80] Nicol, 2014, Abnormal infant islet morphology precedes insulin resistance in PCOS-like monkeys, PLoS One source
Not checked in the free run.
- Premisecitation
Fetal, neonatal, prepubertal, and/or pubertal ovaries may be genetically predisposed to increased androgen secretion.
“Fetal, neonatal, prepubertal, and/or pubertal ovaries may be genetically predisposed to increased androgen secretion [100, 101].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [100] Abbott, 2002, Developmental origin of polycystic ovary syndrome—a hypothesis, J Endocrinol source
Not checked in the free run.
- cites [101] Abbott, 2005, Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome, Hum Reprod Update source
Not checked in the free run.
- Premisecitation
Genes involved in HPO axis function, that is, LHCGR, FSHR, and FSHB, were identified in these GWASs implicating gonadotropins in the pathophysiology of PCOS.
“Genes involved in HPO axis function, that is, LHCGR, FSHR, and FSHB, were identified in these GWASs implicating gonadotropins in the pathophysiology of PCOS [115].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [115] Hayes, 2015, Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations [published correction appears in Nat Commun. 2016;7:10762], Nat Commun source
Not checked in the free run.
- Interpretationcitation
These data are consistent with the hypothesis that complex disorders such as PCOS are associated with genetic variations in noncoding regions.
“Using family-based quantitative trait meta-analysis, rare DENND1A variants were associated with metabolic and reproductive traits in PCOS families; these data are consistent with the hypothesis that complex disorders such as PCOS are associated with genetic variations in noncoding regions [119].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [119] Dapas
Not checked in the free run.
- Premisecitation
One report involving 23 mothers self-reporting PCOS and 277 women reporting no PCOS indicated increased anogenital differences, a marker of prenatal androgen exposure, in daughters of women with PCOS.
“One report involving 23 mothers self-reporting PCOS and 277 women reporting no PCOS indicated increased anogenital differences, a marker of prenatal androgen exposure, in daughters of women with PCOS [104].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [104] Barrett, 2018, Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure, J Dev Orig Health Dis source
Not checked in the free run.
- Premisecitation
Similarities between normal pubertal development and the clinical features associated with PCOS confound the diagnosis in adolescent girls.
“These similarities between normal pubertal development and the clinical features associated with PCOS confound the diagnosis in adolescent girls (Table 1) [125–127].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [125] Teede, 2018, Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome, Clin Endocrinol (Oxf) source
Not checked in the free run.
- cites [126] Ibáñez, 2017, An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence, Horm Res Paediatr source
Not checked in the free run.
- cites [127] Witchel, 2015, The diagnosis of polycystic ovary syndrome during adolescence, Horm Res Paediatr source
Not checked in the free run.
- Premisecitation
In rhesus monkeys, the combination of a high-fat diet and testosterone treatment accelerated development of white adipose tissue dysfunction.
“In a treatment paradigm comparing a high-fat diet with/or without testosterone treatment in rhesus monkeys, the combination of a high-fat diet and testosterone treatment accelerated development of white adipose tissue dysfunction [98].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [98] Varlamov, 2017, Combined androgen excess and Western-style diet accelerates adipose tissue dysfunction in young adult, female nonhuman primates, Hum Reprod source
Not checked in the free run.
- Premisecitation
Impaired adipocyte differentiation has been demonstrated in nonhuman primate models.
“Impaired adipocyte differentiation has been demonstrated in NHP models [105].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [105] Keller, 2014, Impaired preadipocyte differentiation into adipocytes in subcutaneous abdominal adipose of PCOS-like female rhesus monkeys, Endocrinology source
Not checked in the free run.
- Premisecitation
Among prenatally androgenized nonhuman primates, when the capacity of subcutaneous adipocytes to store fat is exceeded, excess free fatty acids may be deposited in ectopic locations such as liver and muscle.
“Among prenatally androgenized NHPs, when the capacity of subcutaneous adipocytes to store fat is exceeded, excess free fatty acids may be deposited in ectopic locations such a liver and muscle; consequences of ectopic fat deposition may include impaired tissue hypoxia, inflammation, and IR [106].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [106] True, 2017, Sex differences in androgen regulation of metabolism in nonhuman primates, Adv Exp Med Biol source
Not checked in the free run.
- Premisecitation
A meta-analysis showed that identified loci are linked to genes plausibly associated with the metabolic and reproductive characteristics of PCOS.
“A meta-analysis showed that identified loci are linked to genes plausibly associated with the metabolic and reproductive characteristics of PCOS [118].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [118] Day, 2018, Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria, PLoS Genet source
Not checked in the free run.
- Premisecitation
Available data support the hypothesis that prenatal androgen exposure programs the neuroendocrine, metabolic, and reproductive manifestations of PCOS.
“Available data support the hypothesis that prenatal androgen exposure programs the neuroendocrine, metabolic, and reproductive manifestations of PCOS [103].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [103] Abbott, 2013, Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood, Fertil Steril source
Not checked in the free run.
- Premisecitation
A deep in vivo metabolic phenotyping study showed increased AKR1C3 and decreased SRD5A1 mRNA expression in subcutaneous fat of women with PCOS.
“A deep in vivo metabolic phenotyping study showed increased AKR1C3 and decreased SRD5A1 mRNA expression in subcutaneous fat of women with PCOS [95].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [95] O’Reilly, 2017, AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome, J Clin Endocrinol Metab source
Not checked in the free run.
- Rests on an assumption: The enzyme aldo-ketoreductase type 1C, encoded by the AKR1C3 gene, is expressed in adipose tissue and converts the preandrogen androstenedione to testosterone.
- Rests on an assumption: The enzyme 5α-reductase type 1, encoded by the SRD5A1 gene, converts testosterone to DHT and is expressed in adipose tissue.
- Premisecitation
Decreased α-diversity has been described in women with PCOS.
“Decreased α-diversity has been described in women with PCOS [109, 110].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [109] Insenser, 2018, Gut microbiota and the polycystic ovary syndrome: influence of sex, sex hormones, and obesity, J Clin Endocrinol Metab source
Not checked in the free run.
- cites [110] Torres, 2018, Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism, J Clin Endocrinol Metab source
Not checked in the free run.
- Premisecitation
Using family-based quantitative trait meta-analysis, rare DENND1A variants were associated with metabolic and reproductive traits in PCOS families.
“Using family-based quantitative trait meta-analysis, rare DENND1A variants were associated with metabolic and reproductive traits in PCOS families; these data are consistent with the hypothesis that complex disorders such as PCOS are associated with genetic variations in noncoding regions [119].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [119] Dapas
Not checked in the free run.
- Premisecitation
In the human preadipocyte cell line, insulin increased AKR1C3 expression.
“Using this model system, insulin increased AKR1C3 expression.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [95] O’Reilly, 2017, AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome, J Clin Endocrinol Metab source
Not checked in the free run.
- Premisecitation
In a human preadipocyte cell line, both testosterone and DHT increased de novo lipogenesis in the absence of insulin.
“Using a human preadipocyte cell line, both testosterone and DHT increased de novo lipogenesis in the absence of insulin [95], whereas pharmacologic inhibition of AKR1C3 activity prevented androgen-mediated adverse effects on adipocyte lipogenesis.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [95] O’Reilly, 2017, AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome, J Clin Endocrinol Metab source
Not checked in the free run.
- Premisecitation
Delineating appropriate diagnostic criteria for PCOS among adolescent girls has been problematic because irregular menses, cystic acne, mild hyperandrogenism, and multifollicular ovarian morphology occur during normal pubertal maturation.
“However, delineating appropriate diagnostic criteria for PCOS among adolescent girls has been problematic because irregular menses, cystic acne, mild hyperandrogenism, and multifollicular ovarian morphology occur during normal pubertal maturation.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [125] Teede, 2018, Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome, Clin Endocrinol (Oxf) source
Not checked in the free run.
- cites [126] Ibáñez, 2017, An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence, Horm Res Paediatr source
Not checked in the free run.
- cites [127] Witchel, 2015, The diagnosis of polycystic ovary syndrome during adolescence, Horm Res Paediatr source
Not checked in the free run.
- Premisecitation
Twin studies suggest that the hereditability of PCOS is approximately 70%.
“Twin studies suggest that the hereditability is ∼70% [112].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [112] Vink, 2006, Heritability of polycystic ovary syndrome in a Dutch twin-family study, J Clin Endocrinol Metab source
Not checked in the free run.
- Premisecitation
With the exception of the GATA4/NEIL2 locus, the genetic architecture did not differ whether National Institutes of Health or Rotterdam criteria were used to diagnose PCOS.
“With the exception of the GATA4/NEIL2 locus, the genetic architecture did not differ whether National Institutes of Health or Rotterdam criteria were used to diagnose PCOS [118].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [118] Day, 2018, Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria, PLoS Genet source
Not checked in the free run.
- Premisecitation
The transient insulin resistance and hyperinsulinemia typical of early puberty may kindle the factors associated with development of PCOS.
“The transient IR and hyperinsulinemia typical of early puberty may kindle the factors associated with development of PCOS [74, 75].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Obesity exacerbates the symptoms of PCOS, especially regarding the risk for development of type 2 diabetes and the metabolic syndrome.
“One relatively consistent finding is that obesity exacerbates the symptoms of PCOS, especially regarding the risk for development of T2D and the metabolic syndrome [76].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [76] Moran, 2010, Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis, Hum Reprod Update source
Not checked in the free run.
- Premisecitation
GWASs involving women of Han Chinese and European origins have identified at least 16 susceptibility loci for PCOS.
“GWASs involving women of Han Chinese and European origins have identified at least 16 susceptibility loci for PCOS [113–116].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [113] Chen, 2011, Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3, Nat Genet source
Not checked in the free run.
- cites [114] Shi, 2012, Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome, Nat Genet source
Not checked in the free run.
- cites [115] Hayes, 2015, Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations [published correction appears in Nat Commun. 2016;7:10762], Nat Commun source
Not checked in the free run.
- cites [116] Day, 2015, Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome, Nat Commun source
Not checked in the free run.
- Premisecitation
Linkage disequilibrium score regression analysis demonstrated genetic correlations with metabolic traits, that is, fasting insulin, lipid levels, and PCOS.
“Linkage disequilibrium score regression analysis demonstrated genetic correlations with metabolic traits, that is, fasting insulin, lipid levels, and PCOS.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [118] Day, 2018, Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria, PLoS Genet source
Not checked in the free run.
- Premisecitation
Pharmacologic inhibition of AKR1C3 activity prevented androgen-mediated adverse effects on adipocyte lipogenesis.
“Using a human preadipocyte cell line, both testosterone and DHT increased de novo lipogenesis in the absence of insulin [95], whereas pharmacologic inhibition of AKR1C3 activity prevented androgen-mediated adverse effects on adipocyte lipogenesis.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [95] O’Reilly, 2017, AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome, J Clin Endocrinol Metab source
Not checked in the free run.
- Premisecitation
With the exception of a single publication, none of the current definitions, recommendations, or guidelines includes insulin resistance and/or hyperinsulinemia as a diagnostic feature.
“However, with the exception of a single publication, none of the current definitions, recommendations, or guidelines includes IR and/or hyperinsulinemia as a diagnostic feature [153].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [153] Sultan, 2006, Clinical expression of polycystic ovary syndrome in adolescent girls, Fertil Steril source
Not checked in the free run.
- Premisecitation
Lifestyle interventions in adolescents with PCOS have shown additional improvements in quality of life.
“Lifestyle interventions in adolescents with PCOS have shown additional improvements in quality of life [160, 164, 165].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [160] Lass, 2011, Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls, J Clin Endocrinol Metab source
Not checked in the free run.
- cites [164] Hoeger, 2008, The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials, J Clin Endocrinol Metab source
Not checked in the free run.
- cites [165] Harris-Glocker, 2010, Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin, Fertil Steril source
Not checked in the free run.
- Premisecitation
A meta-analysis of metformin use with and without lifestyle changes in PCOS (including two RCTs in adolescents) showed beneficial effects on BMI and menstrual cycles.
“A meta-analysis of metformin use with and without lifestyle changes in PCOS (including two RCTs in adolescents [164, 178]) showed beneficial effects on BMI and menstrual cycles [164, 178, 179].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [164] Hoeger, 2008, The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials, J Clin Endocrinol Metab source
Not checked in the free run.
- cites [178] Ladson, 2011, Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study, Fertil Steril source
Not checked in the free run.
- cites [179] Naderpoor, 2015, Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis, Hum Reprod Update source
Not checked in the free run.
- Premisecitation
Exercise interventions can also improve cardiometabolic risk factors in women with PCOS.
“Exercise interventions can also improve cardiometabolic risk factors in women with PCOS [171].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [171] Benham, 2018, Role of exercise training in polycystic ovary syndrome: a systematic review and meta-analysis, Clin Obes source
Not checked in the free run.
- Premisecitation
Weight loss strategies up to 7% of body weight have resulted in improving menstrual irregularity and testosterone levels.
“Additionally, weight loss strategies up to 7% of body weight have resulted in improving menstrual irregularity and testosterone levels [164, 167].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [164] Hoeger, 2008, The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials, J Clin Endocrinol Metab source
Not checked in the free run.
- cites [167] Marzouk, 2015, Effect of dietary weight loss on menstrual regularity in obese young adult women with polycystic ovary syndrome, J Pediatr Adolesc Gynecol source
Not checked in the free run.
- Premisecitation
A small open trial shows that cognitive behavior therapy improved depressive symptoms.
“However, family therapy in addition to other lifestyle interventions show beneficial effects on adolescent PCOS symptoms, and a small open trial shows that cognitive behavior therapy improved depressive symptoms [160, 174].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [174] Rofey, 2009, Cognitive–behavioral therapy for physical and emotional disturbances in adolescents with polycystic ovary syndrome: a pilot study, J Pediatr Psychol source
Not checked in the free run.
- Premisecitation
Oligomenorrheic adolescents tend to have persistent oligomenorrhea.
“Oligomenorrheic adolescents tend to have persistent oligomenorrhea [138, 139].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [138] van Hooff, 2004, Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years, Hum Reprod source
Not checked in the free run.
- cites [139] Southam, 1966, The prognosis for adolescents with menstrual abnormalities, Am J Obstet Gynecol source
Not checked in the free run.
- Premisecitation
Alternative exercise activities such as yoga for 12 weeks can also improve PCOS symptoms during adolescence.
“Alternative exercise activities such as yoga for 12 weeks can also improve PCOS symptoms during adolescence [172].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [172] Nidhi, 2012, Effect of holistic yoga program on anxiety symptoms in adolescent girls with polycystic ovarian syndrome: a randomized control trial, Int J Yoga source
Not checked in the free run.
- Premisecitation
AMH concentrations were found to be higher in girls with obesity with PCOS compared to girls with obesity without PCOS of comparable age and pubertal status.
“AMH concentrations were found to be higher in girls with obesity with PCOS compared to girls with obesity without PCOS of comparable age and pubertal status [152].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [152] Kim, 2017, Anti-Müllerian hormone in obese adolescent girls with polycystic ovary syndrome, J Adolesc Health source
Not checked in the free run.
- Premisecitation
Family therapy in addition to other lifestyle interventions shows beneficial effects on adolescent PCOS symptoms.
“However, family therapy in addition to other lifestyle interventions show beneficial effects on adolescent PCOS symptoms, and a small open trial shows that cognitive behavior therapy improved depressive symptoms [160, 174].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [160] Lass, 2011, Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls, J Clin Endocrinol Metab source
Not checked in the free run.
- cites [174] Rofey, 2009, Cognitive–behavioral therapy for physical and emotional disturbances in adolescents with polycystic ovary syndrome: a pilot study, J Pediatr Psychol source
Not checked in the free run.
- Premisecitation
Obesity exacerbates metabolic and psychological comorbidities of PCOS.
“Prevention of weight gain and effective weight management is important in adolescent PCOS, as obesity exacerbates metabolic and psychological comorbidities of PCOS [175, 176].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [175] Li, 2017, Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis, J Obstet Gynaecol source
Not checked in the free run.
- cites [176] Trent, 2005, Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life, Ambul Pediatr source
Not checked in the free run.
- Premisecitation
Ovulation may occur despite irregular menses.
“Importantly, ovulation may occur despite irregular menses [134].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [134] Peña, 2018, The majority of irregular menstrual cycles in adolescence are ovulatory: results of a prospective study, Arch Dis Child source
Not checked in the free run.
- Premisecitation
Two systematic reviews of lifestyle interventions in women with PCOS show improvements in weight, hyperandrogenism, and insulin resistance.
“Two systematic reviews of lifestyle interventions in women with PCOS show improvements in weight, hyperandrogenism, and IR [162, 163].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [162] Moran, 2011, Lifestyle changes in women with polycystic ovary syndrome, Cochrane Database Syst Rev
Not checked in the free run.
- cites [163] Domecq, 2013, Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis, J Clin Endocrinol Metab source
Not checked in the free run.
- Premisecitation
By the third year after menarche, 10 or more menses occur annually in 90% of adolescent girls.
“By the third year after menarche, 10 or more menses occur annually in 90% of adolescent girls [132].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [132] Legro, 2000, Rapid maturation of the reproductive axis during perimenarche independent of body composition, J Clin Endocrinol Metab
Not checked in the free run.
- Interpretationcitation
Coordinated development of all components of the HPO axis may take up to 5 years postmenarche.
“A pilot study entailing serial hormone concentrations and ultrasound studies in ovulatory postmenarcheal girls revealed lower steroid (estrogen and progesterone) concentrations, slower dominant follicle growth rate, and longer follicular phases compared with adult women; these data suggest that coordinated development of all components of the HPO axis may take up to 5 years postmenarche [136, 137]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [136] Sun, 2019, Healthy post-menarchal adolescent girls demonstrate multi-level reproductive axis immaturity, J Clin Endocrinol Metab source
Not checked in the free run.
- cites [137] Treloar, 1967, Variation of the human menstrual cycle through reproductive life, Int J Fertil
Not checked in the free run.
- Premisecitation
Ethnic and genetic variations influence the development of hirsutism.
“Ethnic and genetic variations influence the development of hirsutism [141].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [141] Yildiz, 2010, Visually scoring hirsutism, Hum Reprod Update source
Not checked in the free run.
- Premisecitation
Moderate to vigorous physical activity for at least 60 minutes per day is associated with better physical and psychosocial health in children and adolescents.
“Importantly, moderate to vigorous physical activity for at least 60 minutes per day is associated with better physical and psychosocial health in children and adolescents [169].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [169] Poitras, 2016, Systematic review of the relationships between objectively measured physical activity and health indicators in school-aged children and youth, Appl Physiol Nutr Metab source
Not checked in the free run.
- Premisecitation
A 2018 systemic review of menstrual patterns during the first gynecologic year concluded that menstrual and ovulatory patterns are diverse during this time period.
“A 2018 systemic review of menstrual patterns during the first gynecologic year concluded that menstrual and ovulatory patterns are diverse during this time period.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [135] Gunn, 2018, Menstrual patterns in the first gynecological year: a systematic review, J Pediatr Adolesc Gynecol source
Not checked in the free run.
- Premisecitation
AMH concentrations have been found to be elevated in nonobese girls with PCOS.
“Although it is premature to use AMH concentrations to diagnose PCOS, AMH concentrations have been found to be elevated in nonobese girls with PCOS [150, 151].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [150] Tokmak, 2015, Is anti-Mullerian hormone a good diagnostic marker for adolescent and young adult patients with Polycystic ovary syndrome, Turk J Obstet Gynecol source
Not checked in the free run.
- cites [151] Sopher, 2014, Anti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents, J Pediatr Endocrinol Metab
Not checked in the free run.
- Premisecitation
Approximately 41% of girls have achieved ovulatory cycles by the fourth gynecologic year.
“Approximately 41% of girls have achieved ovulatory cycles by the fourth gynecologic year [133].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [133] Vihko, 1984, Endocrine characteristics of adolescent menstrual cycles: impact of early menarche, J Steroid Biochem source
Not checked in the free run.
- Premisecitation
Measuring 11-oxo-androgens shows promise as a method to assess for hyperandrogenism.
“Measuring 11-oxo-androgens shows promise as a method to assess for hyperandrogenism [144, 145].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [144] Turcu, 2017, Clinical significance of 11-oxygenated androgens, Curr Opin Endocrinol Diabetes Obes source
Not checked in the free run.
- cites [145] Pretorius, 2017, A new dawn for androgens: novel lessons from 11-oxygenated C19 steroids, Mol Cell Endocrinol source
Not checked in the free run.
- Premisecitation
Depending on ethnicity, a modified Ferriman-Gallwey score ≥4 to 6 indicates hirsutism.
“Depending on ethnicity, a modified Ferriman–Gallwey score ≥4 to 6 indicates hirsutism [125].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [125] Teede, 2018, Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome, Clin Endocrinol (Oxf) source
Not checked in the free run.
- Premisecitation
It is commonly used in adolescents 15 to 19 years of age despite being "off label" for this indication.
“It is commonly used in adolescents 15 to 19 years of age despite being “off label” for this indication [177].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [177] Wang, 2016, Metformin prescription patterns among US adolescents aged 10–19 years: 2009–2013, J Clin Pharm Ther source
Not checked in the free run.
- Premisecitation
The Canadian Laboratory Initiative in Pediatric Reference Intervals (CALIPER) project has developed sensitive and accurate liquid chromatography-tandem mass spectrometry methodology to simultaneously measure eight steroids.
“In view of these constraints, the Canadian Laboratory Initiative in Pediatric Reference Intervals (CALIPER) project has developed sensitive and accurate liquid chromatography–tandem mass spectrometry methodology to simultaneously measure eight steroids [143].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [143] Kyriakopoulou, 2013, A sensitive and rapid mass spectrometric method for the simultaneous measurement of eight steroid hormones and CALIPER pediatric reference intervals, Clin Biochem source
Not checked in the free run.
- Premisecitation
Flutamide has been associated with severe side effects such as liver toxicity.
“Flutamide has been associated with severe side effects such as liver toxicity [191, 207].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [191] Somani, 2014, Hirsutism: an evidence-based treatment update, Am J Clin Dermatol source
Not checked in the free run.
- cites [207] Domecq, 2013, Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis, J Clin Endocrinol Metab source
Not checked in the free run.
- Premisecitation
Multiple observational studies and six RCTs evaluating the effect of metformin on a total of 275 adolescents with PCOS have demonstrated short-term beneficial effects mostly in adolescents with overweight/obesity.
“There have been multiple observational studies and six RCTs evaluating the effect of metformin on a total of 275 adolescents with PCOS. These studies have demonstrated short-term beneficial effects mostly in adolescents with overweight/obesity [164, 180–183].”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [164] Hoeger, 2008, The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials, J Clin Endocrinol Metab source
Not checked in the free run.
- cites [180] Allen, 2005, Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome, J Pediatr Endocrinol Metab source
Not checked in the free run.
- cites [181] Bridger, 2006, Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome, Arch Pediatr Adolesc Med source
Not checked in the free run.
- cites [182] Al-Zubeidi, 2015, Randomized clinical trial evaluating metformin versus oral contraceptive pills in the treatment of adolescents with polycystic ovarian syndrome, J Pediatr Endocrinol Metab source
Not checked in the free run.
- cites [183] El Maghraby, 2015, Randomized controlled trial of the effects of metformin versus combined oral contraceptives in adolescent PCOS women through a 24 month follow up period, Middle East Fertil Soc J source
Not checked in the free run.
- Premisecitation
Meta-analyses including larger number of RCTs in women with PCOS showed limited or no benefit of insulin sensitizers on hirsutism.
“Meta-analyses including larger number of RCTs in women with PCOS showed limited or no benefit of insulin sensitizers on hirsutism [185, 186].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [185] Cosma, 2008, Clinical review: insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials, J Clin Endocrinol Metab source
Not checked in the free run.
- cites [186] Barrionuevo, 2018, Treatment options for hirsutism: a systematic review and network meta-analysis, J Clin Endocrinol Metab source
Not checked in the free run.
- Premisecitation
A small RCT involving adolescents with PCOS showed no difference in hirsutism improvement when two COCPs were compared during 12 months (30 μg of ethinyl estradiol and 0.15 mg of desogestrel vs 35 μg of ethinyl estradiol and 2 mg of cyproterone acetate).
“A small RCT involving adolescents with PCOS showed no difference in hirsutism improvement when two COCPs were compared during 12 months (30 µg of ethinyl estradiol and 0.15 mg of desogestrel vs 35 µg of ethinyl estradiol and 2 mg of cyproterone acetate) [204].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [204] Mastorakos, 2002, Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives, Fertil Steril source
Not checked in the free run.
- Premisecitation
COCPs alone improve hirsutism in adolescents with PCOS.
“COCPs alone improve hirsutism in adolescents with PCOS [184].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [184] Al Khalifah, 2016, Metformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis, Pediatrics source
Not checked in the free run.
- Premisecitation
Improvement of hirsutism with laser has been associated with improvement in quality of life, anxiety, and depression in young women with PCOS.
“Improvement of hirsutism with laser has been associated with improvement in quality of life, anxiety, and depression in young women with PCOS [198, 199].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [198] Maziar, 2010, Unwanted facial hair removal with laser treatment improves quality of life of patients, J Cosmet Laser Ther source
Not checked in the free run.
- cites [199] Clayton, 2005, A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome, Br J Dermatol source
Not checked in the free run.
- Premisecitation
Data on finasteride are very limited even among adult women.
“as data are very limited even among adult women [190].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [190] Pasquali, 2013, Therapy in endocrine disease: treatment of hirsutism in the polycystic ovary syndrome, Eur J Endocrinol source
Not checked in the free run.
- Premisecitation
COCPs improve menstrual irregularity in adolescents with PCOS.
“COCPs improve menstrual irregularity in adolescents with PCOS [164, 180–184].”
Quote in the paperSubstantial claim0 of 6 sources checked- cites [164] Hoeger, 2008, The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials, J Clin Endocrinol Metab source
Not checked in the free run.
- cites [180] Allen, 2005, Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome, J Pediatr Endocrinol Metab source
Not checked in the free run.
- cites [181] Bridger, 2006, Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome, Arch Pediatr Adolesc Med source
Not checked in the free run.
- cites [182] Al-Zubeidi, 2015, Randomized clinical trial evaluating metformin versus oral contraceptive pills in the treatment of adolescents with polycystic ovarian syndrome, J Pediatr Endocrinol Metab source
Not checked in the free run.
- cites [183] El Maghraby, 2015, Randomized controlled trial of the effects of metformin versus combined oral contraceptives in adolescent PCOS women through a 24 month follow up period, Middle East Fertil Soc J source
Not checked in the free run.
- cites [184] Al Khalifah, 2016, Metformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis, Pediatrics source
Not checked in the free run.
- Premisecitation
Metformin at a dose of 1700 to 2000 mg/d is associated with greater improvement of BMI according to a meta-analysis of metformin vs oral contraceptives in adolescents with PCOS and including four RCTs (170 adolescents).
“Metformin at a dose of 1700 to 2000 mg/d is associated with greater improvement of BMI, and COCPs are associated with improvement in menstrual irregularity and acne according to a meta-analysis of metformin vs oral contraceptives in adolescents with PCOS and including four RCTs (170 adolescents) [164, 180–184].”
Quote in the paperSubstantial claim0 of 6 sources checked- cites [164] Hoeger, 2008, The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials, J Clin Endocrinol Metab source
Not checked in the free run.
- cites [180] Allen, 2005, Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome, J Pediatr Endocrinol Metab source
Not checked in the free run.
- cites [181] Bridger, 2006, Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome, Arch Pediatr Adolesc Med source
Not checked in the free run.
- cites [182] Al-Zubeidi, 2015, Randomized clinical trial evaluating metformin versus oral contraceptive pills in the treatment of adolescents with polycystic ovarian syndrome, J Pediatr Endocrinol Metab source
Not checked in the free run.
- cites [183] El Maghraby, 2015, Randomized controlled trial of the effects of metformin versus combined oral contraceptives in adolescent PCOS women through a 24 month follow up period, Middle East Fertil Soc J source
Not checked in the free run.
- cites [184] Al Khalifah, 2016, Metformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis, Pediatrics source
Not checked in the free run.
- Interpretationcitation
Accruing evidence indicates that hyperandrogenism is a pivotal factor affecting multiple tissues in PCOS.
“The list of factors involved in the pathophysiology continues to expand, with accruing evidence indicating that hyperandrogenism is a pivotal factor affecting multiple tissues [220, 221].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [220] Abbott, 2017, Neuronal androgen receptor: molecular gateway to polycystic ovary syndrome, Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [221] Puttabyatappa, 2018, Ovarian and extra-ovarian mediators in the development of polycystic ovary syndrome, J Mol Endocrinol source
Not checked in the free run.
- Rests on an assumption: Data from animal models consistently implicate testosterone as an important factor in the pathogenesis of PCOS.
- Premisecitation
Flutamide at a dose of 250 to 500 mg/d divided in two doses during 12 months has shown beneficial effects on hirsutism in women.
“Flutamide at a dose of 250 to 500 mg/d divided in two doses during 12 months has shown beneficial effects on hirsutism in women”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [191] Somani, 2014, Hirsutism: an evidence-based treatment update, Am J Clin Dermatol source
Not checked in the free run.
- Premisecitation
Additional comorbidities can occur in adolescents with PCOS that might be independent of overweight status.
“Additional comorbidities can occur in adolescents with PCOS that might be independent of overweight status.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [125] Teede, 2018, Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome, Clin Endocrinol (Oxf) source
Not checked in the free run.
- cites [126] Ibáñez, 2017, An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence, Horm Res Paediatr source
Not checked in the free run.
- cites [210] Palmert, 2002, Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome, J Clin Endocrinol Metab source
Not checked in the free run.
- cites [211] Kakoly, 2018, Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression, Hum Reprod Update source
Not checked in the free run.
- Premisecitation
The combination of COCPs and antiandrogens is superior for management of hirsutism.
“The combination of COCPs and antiandrogens is superior for management of hirsutism [186].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [186] Barrionuevo, 2018, Treatment options for hirsutism: a systematic review and network meta-analysis, J Clin Endocrinol Metab source
Not checked in the free run.
- Premisecitation
Low doses of flutamide (125 mg/d) in combination with metformin have been used in adolescents with ovarian hyperandrogenism.
“Low doses of flutamide (125 mg/d) in combination with metformin have been used in adolescents with ovarian hyperandrogenism [206].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [206] Ibáñez, 2003, Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism, J Clin Endocrinol Metab source
Not checked in the free run.
- Premisecitation
These comorbidities include impaired glucose tolerance and type 2 diabetes.
“These comorbidities include impaired glucose tolerance and type 2 diabetes [125, 126, 210, 211].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [125] Teede, 2018, Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome, Clin Endocrinol (Oxf) source
Not checked in the free run.
- cites [126] Ibáñez, 2017, An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence, Horm Res Paediatr source
Not checked in the free run.
- cites [210] Palmert, 2002, Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome, J Clin Endocrinol Metab source
Not checked in the free run.
- cites [211] Kakoly, 2018, Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression, Hum Reprod Update source
Not checked in the free run.
- Premisecitation
GWASs have identified genes common to both Han Chinese and white populations that are involved in neuroendocrine, metabolic, and reproductive pathways.
“GWASs have identified genes common to both Han Chinese and white populations that are involved in neuroendocrine, metabolic, and reproductive pathways [118].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [118] Day, 2018, Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria, PLoS Genet source
Not checked in the free run.
- May combine two claims. 32
- Classified as probably not a substantial claim. 4
May combine two claims.
InterpretationcitationAMH appears to have a dual role: whereas AMH promotes preantral follicle survival, it negatively impacts later stages of antral follicle maturation.
“Hence, AMH appears to have a dual role: whereas AMH promotes preantral follicle survival, it negatively impacts later stages of antral follicle maturation [12].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] Xu, 2016, Anti-Müllerian hormone promotes pre-antral follicle growth, but inhibits antral follicle maturation and dominant follicle selection in primates, Hum Reprod source
Not checked in the free run.
May combine two claims.
PremisecitationAndrogens synthesized in preantral follicle theca cells promote growth of preantral and antral follicles and induce granulosa cell FSH receptor (FSHR) expression in early antral follicles.
“Despite prior assumptions that androgens negatively impact follicles, androgens synthesized in preantral follicle theca cells promote growth of preantral and antral follicles and induce granulosa cell FSH receptor (FSHR) expression in early antral follicles [14].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Weil, 1998, Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations, J Clin Endocrinol Metab source
Not checked in the free run.
May combine two claims.
InterpretationcitationExcessive prenatal AMH exposure could promote the aberrant neuroendocrine function typical of PCOS and AMH can modulate GnRH neuron function.
“These data suggest that excessive prenatal AMH exposure could promote the aberrant neuroendocrine function typical of PCOS and that AMH can modulate GnRH neuron function [37, 38].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [37] Cimino, 2016, Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion, Nat Commun source
Not checked in the free run.
- cites [38] Tata, 2018, Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood, Nat Med source
Not checked in the free run.
May combine two claims.
PremisecitationThe classic ovarian phenotype of enlarged ovaries with string-of-pearl morphology and theca interstitial hyperplasia reflects androgen exposure; this morphology has also been observed in women with congenital adrenal hyperplasia (CAH) and female-to-male transgender individuals.
“The classic ovarian phenotype of enlarged ovaries with string-of-pearl morphology and theca interstitial hyperplasia reflects androgen exposure; this morphology has also been observed in women with congenital adrenal hyperplasia (CAH) and female-to-male transgender individuals [8].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Pache, 1993, Polycystic ovaries in female-to-male transsexuals, Clin Endocrinol (Oxf)
Not checked in the free run.
May combine two claims.
PremisecitationAMH appears to promote growth of preantral follicles to the antral stage in nonhuman primate ovaries, in contrast to mice where AMH inhibits preantral follicle growth and antral follicle maturation.
“In contrast to mice where AMH inhibits preantral follicle growth and antral follicle maturation, AMH appears to promote growth of preantral follicles to the antral stage in nonhuman primate (NHP) ovaries [11, 12].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [11] Carlsson, 2006, Anti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro, Hum Reprod source
Not checked in the free run.
- cites [12] Xu, 2016, Anti-Müllerian hormone promotes pre-antral follicle growth, but inhibits antral follicle maturation and dominant follicle selection in primates, Hum Reprod source
Not checked in the free run.
May combine two claims.
PremisecitationPrepubertal ovaries contain a high proportion of abnormal nongrowing follicles, which are not found in pubertal ovaries.
“Specifically, prepubertal ovaries contain a high proportion of abnormal nongrowing follicles, which are not found in pubertal ovaries [9].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Anderson, 2014, The immature human ovary shows loss of abnormal follicles and increasing follicle developmental competence through childhood and adolescence, Hum Reprod source
Not checked in the free run.
May combine two claims.
PremisecitationPersistent hyperandrogenism is associated with impaired hypothalamic-pituitary feedback, LH hypersecretion, premature granulosa cell luteinization, aberrant oocyte maturation, and premature arrest of activated primary follicles.
“The persistent hyperandrogenism is associated with impaired hypothalamic–pituitary feedback, LH hypersecretion, premature granulosa cell luteinization, aberrant oocyte maturation, and premature arrest of activated primary follicles [4].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Palomba, 2017, Oocyte competence in women with polycystic ovary syndrome, Trends Endocrinol Metab source
Not checked in the free run.
May combine two claims.
PremisecitationNormal-weight adolescent girls with PCOS have peripheral insulin resistance, increased liver fat, and muscle mitochondrial dysfunction compared with normal-weight girls.
“Normal-weight adolescent girls with PCOS have peripheral IR, increased liver fat, and muscle mitochondrial dysfunction compared with normal-weight girls [70].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [70] Cree-Green, 2017, Insulin resistance, hyperinsulinemia, and mitochondria dysfunction in nonobese girls with polycystic ovarian syndrome, J Endocr Soc source
Not checked in the free run.
May combine two claims.
PremisecitationIn PCOS, liver, skeletal muscle, and adipose tissue exhibit insulin resistance, whereas steroid-producing tissues and the pituitary retain insulin sensitivity.
“This leads to the paradox of insulin signaling in PCOS; liver, skeletal muscle, and adipose tissue exhibit IR, whereas steroid-producing tissues and the pituitary retain insulin sensitivity [71, 72].”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationA longitudinal study found that the median age at menarche for American girls was 12.25 years, with lower menarcheal ages in black and Hispanic girls compared with white and Asian girls.
“A longitudinal study found that the median age at menarche for American girls was 12.25 years, with lower menarcheal ages in black and Hispanic girls compared with white and Asian girls [130].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [130] Biro, 2018, Age of menarche in a longitudinal US cohort, J Pediatr Adolesc Gynecol source
Not checked in the free run.
May combine two claims.
PremisecitationConsequences of ectopic fat deposition may include impaired tissue hypoxia, inflammation, and insulin resistance.
“Among prenatally androgenized NHPs, when the capacity of subcutaneous adipocytes to store fat is exceeded, excess free fatty acids may be deposited in ectopic locations such a liver and muscle; consequences of ectopic fat deposition may include impaired tissue hypoxia, inflammation, and IR [106].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [106] True, 2017, Sex differences in androgen regulation of metabolism in nonhuman primates, Adv Exp Med Biol source
Not checked in the free run.
May combine two claims.
InterpretationcitationA mismatch between prenatal weight and postnatal weight gain is associated with increased risk for PCOS, ectopic fat storage, and hepatic steatosis.
“These findings are consistent with the concept that a mismatch between prenatal weight and postnatal weight gain is associated with increased risk for PCOS, ectopic fat storage, and hepatic steatosis [92–94].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [92] Ibáñez, 2014, Hyperinsulinaemic androgen excess in adolescent girls [published correction appears in Nat Rev Endocrinol. 2014;10:578], Nat Rev Endocrinol source
Not checked in the free run.
- cites [93] de Zegher, 2018, Central obesity, faster maturation, and “PCOS” in girls, Trends Endocrinol Metab source
Not checked in the free run.
- cites [94] de Zegher, 2017, Reduced prenatal weight gain and/or augmented postnatal weight gain precedes polycystic ovary syndrome in adolescent girls, Obesity (Silver Spring) source
Not checked in the free run.
May combine two claims.
PremisecitationEarly pubertal nonhuman primates treated with testosterone and a "Western style diet" with increased fat content showed increased larger visceral adipocytes, greater insulin resistance, and ectopic fat storage.
“Early pubertal NHP treated with testosterone and a “Western style diet” with increased fat content showed increased larger visceral adipocytes, greater IR, and ectopic fat storage [106].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [106] True, 2017, Sex differences in androgen regulation of metabolism in nonhuman primates, Adv Exp Med Biol source
Not checked in the free run.
May combine two claims.
PremisecitationGirls with obesity and PCOS compared with girls with obesity without PCOS demonstrated decreased lipid mobilization, diminished fat oxidation, and impaired ability to switch from lipid to carbohydrate oxidation during insulin stimulation (metabolic inflexibility).
“Girls with obesity with PCOS compared with those without PCOS demonstrated decreased lipid mobilization, diminished fat oxidation, and impaired ability to switch from lipid to carbohydrate oxidation during insulin stimulation (metabolic inflexibility) [97].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [97] Kim, 2018, Impaired lipolysis, diminished fat oxidation, and metabolic inflexibility in obese girls with polycystic ovary syndrome, J Clin Endocrinol Metab source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationEpigenetic variants have been reported for adipose tissue and muscle.
“Epigenetic variants have been reported for adipose tissue and muscle [120, 121].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [120] Kokosar, 2016, Epigenetic and transcriptional alterations in human adipose tissue of polycystic ovary syndrome [published correction appears in Sci Rep. 2016;6:25321], Sci Rep source
Not checked in the free run.
- cites [121] Nilsson, 2018, Transcriptional and epigenetic changes influencing skeletal muscle metabolism in women with polycystic ovary syndrome, J Clin Endocrinol Metab source
Not checked in the free run.
May combine two claims.
PremisecitationSeveral genetic variants are similar in both Han Chinese and European populations, implying that PCOS is an ancient disease.
“Several genetic variants are similar in both Han Chinese and European populations, implying that PCOS is an ancient disease [117].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [117] Fessler, 2016, Evolutionary determinants of polycystic ovary syndrome: part 2, Fertil Steril source
Not checked in the free run.
May combine two claims.
PremisecitationActivation of androgen precursors appears to regulate adipocyte proliferation and differentiation, insulin sensitivity, adipokine signaling, and lipid metabolism.
“Activation appears to regulate adipocyte proliferation and differentiation, insulin sensitivity, adipokine signaling, and lipid metabolism [96].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [96] O’Reilly, 2014, Understanding androgen action in adipose tissue, J Steroid Biochem Mol Biol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationBy age 15 years, 98% of girls will have experienced menarche.
“By age 15 years, 98% of girls will have experienced menarche [131].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [131] Chumlea, 2003, Age at menarche and racial comparisons in US girls, Pediatrics source
Not checked in the free run.
May combine two claims.
PremisecitationBoth low-glycemic load and low-fat diets during 6 months improved weight with no difference between diets.
“Similarly, both low–glycemic load and low-fat diets during 6 months improved weight with no difference between diets [168].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [168] Wong, 2016, A randomized pilot study of dietary treatments for polycystic ovary syndrome in adolescents, Pediatr Obes source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe cut point of a basal 17-hydroxyprogesterone >200 ng/dL has been suggested as the threshold for performing ACTH stimulation tests.
“The cut point of a basal 17-hydroxyprogesterone >200 ng/dL has been suggested as the threshold for performing ACTH stimulation tests [148].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [148] Armengaud, 2009, Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche, J Clin Endocrinol Metab source
Not checked in the free run.
May combine two claims.
PremisecitationIn 22 studies involving more than 2000 adolescents, frequent menstrual bleeding (<21 days) occurred in 23% and prolonged menstrual bleeding (>30 to 45 days) occurred in at least 33%.
“In 22 studies involving >2000 adolescents, frequent menstrual bleeding (<21 days) occurred in 23% and prolonged menstrual bleeding (>30 to 45 days) occurred in at least 33% [135].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [135] Gunn, 2018, Menstrual patterns in the first gynecological year: a systematic review, J Pediatr Adolesc Gynecol source
Not checked in the free run.
May combine two claims.
PremisecitationAMH concentrations reflect ovarian reserve and are correlated with the number of growing follicles.
“AMH concentrations reflect ovarian reserve and are correlated with the number of growing follicles [149].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [149] Pigny, 2003, Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest, J Clin Endocrinol Metab source
Not checked in the free run.
May combine two claims.
PremisecitationA low-carbohydrate diet (20 to 40 g/d) and a hypocaloric diet (<40 g of fat per day) during 12 weeks improved weight and menstrual irregularities with no difference between the diets.
“A low-carbohydrate diet (20 to 40 g/d) and a hypocaloric diet (<40 g of fat per day) during 12 weeks improved weight and menstrual irregularities with no difference between the diets.”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [160] Lass, 2011, Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls, J Clin Endocrinol Metab source
Not checked in the free run.
- cites [164] Hoeger, 2008, The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials, J Clin Endocrinol Metab source
Not checked in the free run.
- cites [166] Ornstein, 2011, Effect of weight loss on menstrual function in adolescents with polycystic ovary syndrome, J Pediatr Adolesc Gynecol source
Not checked in the free run.
- cites [167] Marzouk, 2015, Effect of dietary weight loss on menstrual regularity in obese young adult women with polycystic ovary syndrome, J Pediatr Adolesc Gynecol source
Not checked in the free run.
- cites [168] Wong, 2016, A randomized pilot study of dietary treatments for polycystic ovary syndrome in adolescents, Pediatr Obes source
Not checked in the free run.
May combine two claims.
PremisecitationA low-energy diet compared with a healthy diet for 6 months was associated with weight loss, more regular menses, and decreased hirsutism.
“A low-energy diet compared with a healthy diet for 6 months was associated with weight loss, more regular menses, and decreased hirsutism [167].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [167] Marzouk, 2015, Effect of dietary weight loss on menstrual regularity in obese young adult women with polycystic ovary syndrome, J Pediatr Adolesc Gynecol source
Not checked in the free run.
May combine two claims.
PremisecitationPCOM is an inconsistent finding in adolescent girls and is not associated with anovulation or metabolic abnormalities.
“PCOM is an inconsistent finding in adolescent girls and is not associated with anovulation or metabolic abnormalities [147].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [147] Codner, 2011, Polycystic ovarian morphology in postmenarchal adolescents, Fertil Steril source
Not checked in the free run.
May combine two claims.
PremisecitationNutrition education in addition to exercise training and behavioral therapy for 12 months resulted in weight loss, as well as improvement of menstrual irregularities and androgen levels in adolescents with obesity and PCOS.
“Nutrition education in addition to exercise training and behavioral therapy for 12 months resulted in weight loss, as well as improvement of menstrual irregularities and androgen levels in adolescents with obesity and PCOS [160].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [160] Lass, 2011, Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls, J Clin Endocrinol Metab source
Not checked in the free run.
May combine two claims.
PremisecitationA pilot study entailing serial hormone concentrations and ultrasound studies in ovulatory postmenarcheal girls revealed lower steroid (estrogen and progesterone) concentrations, slower dominant follicle growth rate, and longer follicular phases compared with adult women.
“A pilot study entailing serial hormone concentrations and ultrasound studies in ovulatory postmenarcheal girls revealed lower steroid (estrogen and progesterone) concentrations, slower dominant follicle growth rate, and longer follicular phases compared with adult women; these data suggest that coordinated development of all components of the HPO axis may take up to 5 years postmenarche [136, 137]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [136] Sun, 2019, Healthy post-menarchal adolescent girls demonstrate multi-level reproductive axis immaturity, J Clin Endocrinol Metab source
Not checked in the free run.
- cites [137] Treloar, 1967, Variation of the human menstrual cycle through reproductive life, Int J Fertil
Not checked in the free run.
May combine two claims.
PremisecitationAdditional comorbidities include decreased quality of life, depression, anxiety, eating disorders and disordered eating, and altered body image.
“Additional comorbidities include decreased quality of life, depression, anxiety, eating disorders and disordered eating, and altered body image [192, 212–214].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [192] van Zuuren, 2016, Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments, Br J Dermatol source
Not checked in the free run.
- cites [212] Trent, 2002, Quality of life in adolescent girls with polycystic ovary syndrome, Arch Pediatr Adolesc Med source
Not checked in the free run.
- cites [213] Jones, 2011, Health-related quality of life among adolescents with polycystic ovary syndrome, J Obstet Gynecol Neonatal Nurs source
Not checked in the free run.
- cites [214] Guidi, 2015, Psychological aspects of hyperandrogenic states in late adolescent and young women, Clin Endocrinol (Oxf) source
Not checked in the free run.
May combine two claims.
PremisecitationSpironolactone is an aldosterone antagonist that blocks the androgen receptor.
“Spironolactone is an aldosterone antagonist that blocks the AR.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [191] Somani, 2014, Hirsutism: an evidence-based treatment update, Am J Clin Dermatol source
Not checked in the free run.
May combine two claims.
PremisecitationFinasteride is a topical medication that inhibits 5α-reductase.
“Finasteride is a topical medication that inhibits 5α-reductase”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [190] Pasquali, 2013, Therapy in endocrine disease: treatment of hirsutism in the polycystic ovary syndrome, Eur J Endocrinol source
Not checked in the free run.
May combine two claims.
PremisecitationCOCPs are associated with improvement in menstrual irregularity and acne according to a meta-analysis of metformin vs oral contraceptives in adolescents with PCOS.
“Metformin at a dose of 1700 to 2000 mg/d is associated with greater improvement of BMI, and COCPs are associated with improvement in menstrual irregularity and acne according to a meta-analysis of metformin vs oral contraceptives in adolescents with PCOS and including four RCTs (170 adolescents) [164, 180–184].”
Quote in the paperSubstantial claim0 of 6 sources checked- cites [164] Hoeger, 2008, The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials, J Clin Endocrinol Metab source
Not checked in the free run.
- cites [180] Allen, 2005, Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome, J Pediatr Endocrinol Metab source
Not checked in the free run.
- cites [181] Bridger, 2006, Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome, Arch Pediatr Adolesc Med source
Not checked in the free run.
- cites [182] Al-Zubeidi, 2015, Randomized clinical trial evaluating metformin versus oral contraceptive pills in the treatment of adolescents with polycystic ovarian syndrome, J Pediatr Endocrinol Metab source
Not checked in the free run.
- cites [183] El Maghraby, 2015, Randomized controlled trial of the effects of metformin versus combined oral contraceptives in adolescent PCOS women through a 24 month follow up period, Middle East Fertil Soc J source
Not checked in the free run.
- cites [184] Al Khalifah, 2016, Metformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis, Pediatrics source
Not checked in the free run.
May combine two claims.
PremisecitationBoth metformin and oral contraceptives had similar beneficial effects on hirsutism, triglycerides, and high-density lipoprotein cholesterol, but the estimates of effect were derived from low-quality evidence involving small studies.
“Both metformin and oral contraceptives had similar beneficial effects on hirsutism, triglycerides, and high-density lipoprotein cholesterol, but the estimates of effect were derived from low-quality evidence involving small studies [184].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [184] Al Khalifah, 2016, Metformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis, Pediatrics source
Not checked in the free run.
May combine two claims.
PremisecitationLaser treatment was associated with a 50% reduction of hair at 6 months after treatment with mild side effects such as pain, skin redness, and perifollicular edema.
“Laser treatment was associated with a 50% reduction of hair at 6 months after treatment with mild side effects such as pain, skin redness, and perifollicular edema [197].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [197] Haedersdal, 2006, Laser and photoepilation for unwanted hair growth, Cochrane Database Syst Rev
Not checked in the free run.
May combine two claims.
PremisecitationEstrogens in the COCPs decrease free androgens by increasing hepatic production of SHBG and decrease ovarian and adrenal androgen production by suppressing LH levels.
“Estrogens in the COCPs decrease free androgens by increasing hepatic production of SHBG and decrease ovarian and adrenal androgen production by suppressing LH levels [203].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [203] Creatsas, 1993, Treatment of polycystic ovarian disease during adolescence with ethinylestradiol/cyproterone acetate versus a D-Tr-6-LHRH analog, Int J Gynaecol Obstet source
Not checked in the free run.
May combine two claims.
Interpretationnone givenPCOS is a complex disorder involving multiple organ systems with onset during the early pubertal years.
“PCOS is a complex disorder involving multiple organ systems with onset during the early pubertal years (Fig. 1).”
Quote in the paperNot a substantial claim- Rests on an assumption: Data from animal models consistently implicate testosterone as an important factor in the pathogenesis of PCOS.
The paper relies on this without support.
Most available clinical data on PCOS communicate findings and outcomes in adult women.
“Most available clinical data communicate findings and outcomes in adult women.”
The paper relies on this without support.
The Rotterdam criteria are accepted for adult women, and different diagnostic criteria for PCOS in adolescent girls have been delineated.
“Whereas the Rotterdam criteria are accepted for adult women, different diagnostic criteria for PCOS in adolescent girls have been delineated.”
The paper relies on this without support.
The enzyme aldo-ketoreductase type 1C, encoded by the AKR1C3 gene, is expressed in adipose tissue and converts the preandrogen androstenedione to testosterone.
“The enzyme aldo-ketoreductase type 1C, encoded by the AKR1C3 gene, is expressed in adipose tissue and converts the preandrogen androstenedione to testosterone.”
The paper relies on this without support.
The enzyme 5α-reductase type 1, encoded by the SRD5A1 gene, converts testosterone to DHT and is expressed in adipose tissue.
“Additionally, the enzyme 5α-reductase type 1, encoded by the SRD5A1 gene, converts testosterone to DHT and is expressed in adipose tissue.”
The paper relies on this without support.
Contemporary understanding is that it takes 3 to 4 years postmenarche for adult menstrual cyclicity to mature.
“Contemporary understanding is that it takes 3 to 4 years postmenarche for adult menstrual cyclicity to mature.”
The paper relies on this without support.
The severity of hirsutism does not correlate with circulating androgen concentrations.
“The severity of hirsutism does not correlate with circulating androgen concentrations.”
The paper relies on this without support.
Insulin resistance, hyperinsulinemia, and obesity are commonly identified in women with PCOS.
“Insulin resistance, hyperinsulinemia, and obesity are commonly identified in women with PCOS.”
The paper relies on this without support.
Metformin is the single most studied insulin sensitizer in PCOS.
“Metformin is the single most studied insulin sensitizer in PCOS.”
The paper relies on this without support.
Cyproterone acetate is not available in the United States.
“However, cyproterone acetate is not available in the United States.”
The paper relies on this without support.
There are no RCTs evaluating the effect of flutamide alone or in combination with COCPs in adolescents.
“but there are no RCTs evaluating the effect of flutamide alone or in combination with COCPs in adolescents.”
The paper relies on this without support.
Data from animal models consistently implicate testosterone as an important factor in the pathogenesis of PCOS.
“Data obtained from animal models have consistently implicated testosterone as an important factor in the pathogenesis of PCOS.”
The paper relies on this without support.
Acne has a major negative impact on adolescent psychosocial well-being.
“as acne has a major negative impact on adolescent psychosocial well-being.”
The paper relies on this without support.
Psychosocial comorbidities will affect adherence to any interventions.
“as these comorbidities will affect adherence to any interventions.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Cited prenatal-androgen study names a different species
MinorThe text describes the cited study as involving female rhesus monkeys, but reference 59 identifies its subjects as sheep.
“Prenatal androgen exposure during early gestation (late first to second trimester) increased LH and androgen secretion in female rhesus monkeys [59].”
“59. Birch RA, Padmanabhan V, Foster DL, Unsworth WP, Robinson JE Prenatal programming of reproductive neuroendocrine function: fetal androgen exposure produces progressive disruption of reproductive cycles in sheep.”
Cites
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113 · see citing works
Self-citationClinical assessment of body hair growth in women.
Ferriman, D., & Gallwey, J. D. (1961) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,556 · see citing works
Poitras, V. J., Gray, C. E., Borghese, M. M., Carson, V., Chaput, J.-P., Janssen, I., Katzmarzyk, P. T., Pate, R. R., Connor Gorber, S., Kho, M. E., et al. (2016) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2015-0663 · Cited by 2,217 · cited 1× · see citing works
“Importantly, moderate to vigorous physical activity for at least 60 minutes per day is associated with better physical and psychosocial health in children and adolescents [169].”
BackgroundHuman gut microbes impact host serum metabolome and insulin sensitivity
Pedersen, H. K., Gudmundsdottir, V., Nielsen, H. B., Hyotylainen, T., Nielsen, T., Jensen, B. A. H., Forslund, K., Hildebrand, F., Prifti, E., Falony, G., et al. (2016) · Nature · doi:10.1038/nature18646 · Cited by 2,116 · see citing works
Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083 · see citing works
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005 · see citing works
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967 · see citing works
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919 · see citing works
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., & the International PCOS Network (2018) · Clinical Endocrinology · doi:10.1111/cen.13795 · Cited by 1,823 · see citing works
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Samuel, V. T., & Shulman, G. I. (2016) · Journal of Clinical Investigation · doi:10.1172/jci77812 · Cited by 1,484 · cited 1× · see citing works
“IR decreases suppression of adipocyte lipolysis, resulting in increased serum free fatty acids and triglycerides, ultimately leading to increased hepatic de novo lipogenesis and hyperlipidemia [83].”
BackgroundCarson, V., Hunter, S., Kuzik, N., Gray, C. E., Poitras, V. J., Chaput, J.-P., Saunders, T. J., Katzmarzyk, P. T., Okely, A. D., Connor Gorber, S., et al. (2016) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2015-0630 · Cited by 1,380 · see citing works
Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358 · see citing works
Styne, D. M., Arslanian, S. A., Connor, E. L., Farooqi, I. S., Murad, M. H., Silverstein, J. H., & Yanovski, J. A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2573 · Cited by 1,322 · see citing works
Insulin action and resistance in obesity and type 2 diabetes
Czech, M. P. (2017) · Nature Medicine · doi:10.1038/nm.4350 · Cited by 1,258 · see citing works
Dynamics of gonadotropin-releasing hormone release during a pulse.
Moenter, S. M., Brand, R. M., MIDGLEY, A. R., & Karsch, F. J. (1992) · Endocrinology · doi:10.1210/endo.130.1.1727719 · Cited by 1,257 · see citing works
de Ferranti, S. D., Gauvreau, K., Ludwig, D. S., Neufeld, E. J., Newburger, J. W., & Rifai, N. (2004) · Circulation · doi:10.1161/01.cir.0000145117.40114.c7 · Cited by 1,123 · see citing works
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108 · see citing works
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020 · see citing works
Self-citationVARIATION OF THE HUMAN MENSTRUAL CYCLE THROUGH REPRODUCTIVE LIFE
TRELOAR, A. E., BOYNTON, R. E., BEHN, B. G., & BROWN, B. W. (1968) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-196801000-00019 · Cited by 1,018 · see citing works
Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome — An allostatic perspective
Virtue, S., & Vidal-Puig, A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.12.006 · Cited by 1,013 · see citing works
Lim, S. S., Davies, M. J., Norman, R. J., & Moran, L. J. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms030 · Cited by 939 · see citing works
Chen, Z.-J., Zhao, H., He, L., Shi, Y., Qin, Y., Shi, Y., Li, Z., You, L., Zhao, J., Liu, J., et al. (2011) · Nature Genetics · doi:10.1038/ng.732 · Cited by 782 · see citing works
Lehman, M. N., Coolen, L. M., & Goodman, R. L. (2010) · Endocrinology · doi:10.1210/en.2010-0022 · Cited by 768 · see citing works
Stepto, N. K., Cassar, S., Joham, A. E., Hutchison, S. K., Harrison, C. L., Goldstein, R. F., & Teede, H. J. (2013) · Human Reproduction · doi:10.1093/humrep/des463 · Cited by 747 · see citing works
Lifestyle changes in women with polycystic ovary syndrome
Lim, S. S., Hutchison, S. K., Van Ryswyk, E., Norman, R. J., Teede, H. J., & Moran, L. J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506.pub4 · Cited by 725 · see citing works
Pigny, P., Merlen, E., Robert, Y., Cortet-Rudelli, C., Decanter, C., Jonard, S., & Dewailly, D. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030727 · Cited by 709 · see citing works
Age at menarche and racial comparisons in US girls
Chumlea, W. C., Schubert, C. M., Roche, A. F., Kulin, H. E., Lee, P. A., Himes, J. H., & Sun, S. S. (2003) · PEDIATRICS · doi:10.1542/peds.111.1.110 · Cited by 685 · see citing works
Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome
Shi, Y., Zhao, H., Shi, Y., Cao, Y., Yang, D., Li, Z., Zhang, B., Liang, X., Li, T., Chen, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2384 · Cited by 678 · see citing works
Wildt, L., Häusler, A., Marshall, G. R., HUTCHISON, J. S., Plant, T. M., Belchetz, P. E., & Knobil, E. (1981) · Endocrinology · doi:10.1210/endo-109-2-376 · Cited by 678 · see citing works
Osmond, C., & Barker, D. J. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108s3545 · Cited by 656 · see citing works
Heritability of polycystic ovary syndrome in a Dutch twin-family study
Vink, J. M., Sadrzadeh, S., Lambalk, C. B., & Boomsma, D. I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1494 · Cited by 647 · see citing works
Child Health, Developmental Plasticity, and Epigenetic Programming
Hochberg, Z., Feil, R., Constância, M., Fraga, M. F., Junien, C., Carel, J., Boileau, P., Bouc, Y. L., Deal, C., Lillycrop, K. A., et al. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0039 · Cited by 631 · see citing works
Day, F., Karaderi, T., Jones, M. R., Meun, C., He, C., Drong, A., Kraft, P., Lin, N., Huang, H., Broer, L., et al. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007813 · Cited by 619 · see citing works
Wakabayashi, Y., Nakada, T., Murata, K., Ohkura, S., Mogi, K., Navarro, V. M., Clifton, D. K., Mori, Y., Tsukamura, H., Maeda, K.-I., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5848-09.2010 · Cited by 597 · cited 1× · see citing works
“Although GnRH and LH pulses generally exhibit a 1:1 ratio, preclinical data exist suggesting that a faster GnRH pulse frequency may be associated with decreased LH secretion [52].”
BackgroundNelson, V. L., Legro, R. S., Strauss, J. F., & McAllister, J. M. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.6.0311 · Cited by 556 · see citing works
Abbott, D. H., Barnett, D. K., Bruns, C. M., & Dumesic, D. A. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi013 · Cited by 555 · see citing works
Dewailly, D., Lujan, M. E., Carmina, E., Cedars, M. I., Laven, J., Norman, R. J., & Escobar-Morreale, H. F. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt061 · Cited by 551 · see citing works
Formation and early development of follicles in the polycystic ovary
Webber, L. J., Stubbs, S. A., Stark, J., Trew, G. H., Margara, R. A., Hardy, K., & Franks, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14410-8 · Cited by 521 · see citing works
Astrocytic Insulin Signaling Couples Brain Glucose Uptake with Nutrient Availability
García‐Cáceres, C., Quarta, C., Varela, L., Gao, Y., Gruber, T., Legutko, B., Jastroch, M., Johansson, P., Ninkovic, J., Yi, C., et al. (2016) · Cell · doi:10.1016/j.cell.2016.07.028 · Cited by 516 · see citing works
Control of puberty onset and fertility by gonadotropin-releasing hormone neurons
Herbison, A. E. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.70 · Cited by 515 · see citing works
Martin, K. A., Chang, R. J., Ehrmann, D. A., Ibáñez, L., Løbo, R. A., Rosenfield, R. L., Shapiro, J., Montori, V. M., & Swiglo, B. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2437 · Cited by 506 · see citing works
Developmental origin of polycystic ovary syndrome—a hypothesis
Abbott, D., Dumesic, D., & Franks, S. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1740001 · Cited by 504 · see citing works
Hypothalamic Tanycytes Are an ERK-Gated Conduit for Leptin into the Brain
Balland, É., Dam, J., Langlet, F., Caron, É., Steculorum, S. M., Messina, A., Rasika, S., Falluel‐Morel, A., Anouar, Y., Dehouck, B., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.12.015 · Cited by 500 · see citing works
Hayes, M. G., Urbanek, M., Ehrmann, D. A., Armstrong, L. L., Lee, J. Y., Sisk, R., Karaderi, T., Barber, T. M., McCarthy, M. I., Franks, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8502 · Cited by 478 · see citing works
Ibáñez, L., Oberfield, S. E., Witchel, S., Auchus, R. J., Chang, R. J., Codner, E., Dabadghao, P., Darendeliler, F., Elbarbary, N. S., Gambineri, A., et al. (2017) · Hormone Research in Paediatrics · doi:10.1159/000479371 · Cited by 463 · see citing works
Self-citationDay, F. R., Hinds, D. A., Tung, J. Y., Stolk, L., Styrkarsdottir, U., Saxena, R., Bjonnes, A., Broer, L., Dunger, D. B., Halldorsson, B. V., et al. (2015) · Nature Communications · doi:10.1038/ncomms9464 · Cited by 459 · see citing works
Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries
Gilling‐Smith, C., Willis, D., Beard, R. W., & Franks, S. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962289 · Cited by 436 · see citing works
Tata, B., Mimouni, N. E. H., Barbotin, A.-L., Malone, S. A., Loyens, A., Pigny, P., Dewailly, D., Catteau-Jonard, S., Sundström-Poromaa, I., Piltonen, T. T., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0035-5 · Cited by 434 · see citing works
Gibson-Helm, M., Teede, H., Dunaif, A., & Dokras, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2963 · Cited by 428 · see citing works
Cimino, I., Casoni, F., Liu, X., Messina, A., Parkash, J., Jamin, S. P., Catteau-Jonard, S., Collier, F., Baroncini, M., Dewailly, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms10055 · Cited by 404 · see citing works
Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism
Torres, P. J., Siakowska, M., Banaszewska, B., Pawelczyk, L., Duleba, A. J., Kelley, S. T., & Thackray, V. G. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02153 · Cited by 399 · see citing works
Yildiz, B. O., Bolour, S., Woods, K., Moore, A., & Azziz, R. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp024 · Cited by 395 · see citing works
Kakoly, N. S., Khomami, M. B., Joham, A. E., Cooray, S. D., Misso, M. L., Norman, R. J., Harrison, C. L., Ranasinha, S., Teede, H. J., & Moran, L. J. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmy007 · Cited by 384 · see citing works
Valproate: Past, Present, and Future
Johannessen, C. U., & Johannessen, S. I. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00249.x · Cited by 363 · see citing works
Weil, S. J., Vendola, K., Zhou, J., Adesanya, O. O., Wang, J., Okafor, J., & Bondy, C. A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4917 · Cited by 359 · see citing works
Screening for Abnormal Glucose Tolerance in Adolescents with Polycystic Ovary Syndrome
Palmert, M. R., Gordon, C. M., Kartashov, A. I., Legro, R. S., Emans, S. J., & Dunaif, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8305 · Cited by 354 · see citing works
Longitudinal study of physiologic insulin resistance and metabolic changes of puberty
Hannon, T. S., Janosky, J., & Arslanian, S. A. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000246097.73031.27 · Cited by 353 · see citing works
The backdoor pathway to dihydrotestosterone
Auchus, R. J. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.09.004 · Cited by 347 · see citing works
Naderpoor, N., Shorakae, S., de Courten, B., Misso, M. L., Moran, L. J., & Teede, H. J. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv025 · Cited by 334 · cited 1× · see citing works
“A meta-analysis of metformin use with and without lifestyle changes in PCOS (including two RCTs in adolescents [164, 178]) showed beneficial effects on BMI andmenstrual cycles [164, 178, 179].”
Role of astrocytes, microglia, and tanycytes in brain control of systemic metabolism
García‐Cáceres, C., Balland, É., Prévot, V., Luquet, S. H., Woods, S. C., Koch, M., Horváth, T. L., Yi, C., Chowen, J. A., Verkhratsky, A., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0286-y · Cited by 326 · see citing works
Lim, S. S., Kakoly, N. S., Tan, J. W. J., Fitzgerald, G., Bahri Khomami, M., Joham, A. E., Cooray, S. D., Misso, M. L., Norman, R. J., Harrison, C. L., et al. (2019) · Obesity Reviews · doi:10.1111/obr.12762 · Cited by 316 · see citing works
Sen, A., & Hammes, S. R. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0006 · Cited by 313 · see citing works
Gut microbiota and the polycystic ovary syndrome: influence of sex, sex hormones, and obesity
Insenser, M., Murri, M., del Campo, R., Martínez-García, M. Á., Fernández-Durán, E., & Escobar-Morreale, H. F. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02799 · Cited by 312 · see citing works
Sullivan, S. D., & Moenter, S. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308058101 · Cited by 309 · see citing works
Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome
Gilling‐Smith, C., Story, H., Rogers, V., & Franks, S. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2321049.x · Cited by 301 · see citing works
The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome
Blank, S. K., McCartney, C. R., & Marshall, J. C. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml017 · Cited by 301 · see citing works
Anti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro
Carlsson, I. B. (2006) · Human Reproduction · doi:10.1093/humrep/del165 · Cited by 294 · see citing works
Oocyte competence in women with polycystic ovary syndrome
Palomba, S., Daolio, J., & La Sala, G. B. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.11.008 · Cited by 294 · see citing works
Lifestyle changes in women with polycystic ovary syndrome
Moran, L. J., Hutchison, S. K., Norman, R. J., & Teede, H. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506.pub3 · Cited by 292 · see citing works
Activation of A-Type γ-Aminobutyric Acid Receptors Excites Gonadotropin-Releasing Hormone Neurons
DeFazio, R. A., Heger, S., Ojeda, S. R., & Moenter, S. M. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0163 · Cited by 287 · see citing works
The Versatile Tanycyte: A Hypothalamic Integrator of Reproduction and Energy Metabolism
Prévot, V., Dehouck, B., Sharif, A., Ciofi, P., Giacobini, P., & Clasadonte, J. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00235 · Cited by 271 · see citing works
Exercise therapy in polycystic ovary syndrome: a systematic review
Harrison, C. L., Lombard, C. B., Moran, L. J., & Teede, H. J. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq045 · Cited by 267 · see citing works
11-Oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome
O’Reilly, M. W., Kempegowda, P., Jenkinson, C., Taylor, A. E., Quanson, J. L., Storbeck, K.-H., & Arlt, W. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3285 · Cited by 267 · see citing works
A microRNA switch regulates the rise in hypothalamic GnRH production before puberty
Messina, A., Langlet, F., Chachlaki, K., Roa, J., Rasika, S., Jouy, N., Gallet, S., Gaytán, F., Parkash, J., Tena‐Sempere, M., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4298 · Cited by 257 · see citing works
(1967) · PubMed · Cited by 257 · see citing works
Naderpoor, N., Shorakae, S., de Courten, B. V., Misso, M. L., Moran, L., & Teede, H. J. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmv063 · Cited by 256 · see citing works
Evidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Acne
Eichenfield, L. F., Krakowski, A. C., Piggott, C. D. S., Rosso, J. Q. D., Baldwin, H. E., Friedlander, S. F., Levy, M. L., Lucky, A. W., Mancini, A. J., Orlow, S. J., et al. (2013) · PEDIATRICS · doi:10.1542/peds.2013-0490b · Cited by 256 · see citing works
Hoeger, K., Davidson, K., Kochman, L., Cherry, T., Kopin, L., & Guzick, D. S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0461 · Cited by 256 · see citing works
Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype
McAllister, J. M., Modi, B., Miller, B. A., Biegler, J., Bruggeman, R., Legro, R. S., & Strauss, J. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400574111 · Cited by 250 · see citing works
Toward Excellence in Testosterone Testing: A Consensus Statement
Rosner, W., & Vesper, H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1314 · Cited by 248 · see citing works
Ells, L. J., Rees, K., Brown, T. J., Mead, E., Al-Khudairy, L., Azevedo, L. B., McGeechan, G., Baur, L. A., Loveman, E., Clements, H., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0230-y · Cited by 246 · see citing works
Jeppesen, J. V., Kristensen, S. G., Nielsen, M. E., Humaidan, P., Canto, M. D., Fadini, R., Schmidt, K. T., Ernst, E., & Andersen, C. Y. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1427 · Cited by 244 · see citing works
Maciel, G. A. R., Baracat, E. C., Bénda, J., Markham, S. M., Hensinger, K., Chang, R. J., & Erickson, G. F. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0643 · Cited by 228 · see citing works
Endocrine characteristics of adolescent menstrual cycles: impact of early menarche
Vihko, R., & Apter, D. (1984) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(84)90209-7 · Cited by 227 · see citing works
Rice, S., Christoforidis, N., Gadd, C., Nikolaou, D. S., Seyani, L., Donaldson, A., Margara, R. A., Hardy, K., & Franks, S. (2004) · Human Reproduction · doi:10.1093/humrep/deh609 · Cited by 224 · see citing works
Dumesic, D. A., Akopians, A. L., Madrigal, V. K., Ramirez, E., Margolis, D. J., Sarma, M. K., Thomas, A. M., Grogan, T. R., Haykal, R., Schooler, T. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2586 · Cited by 222 · see citing works
Caldwell, A. S. L., Edwards, M. C., Desai, R., Jimenez, M., Gilchrist, R. B., Handelsman, D. J., & Walters, K. A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616467114 · Cited by 222 · see citing works
O’Reilly, M. W., Kempegowda, P., Walsh, M., Taylor, A. E., Manolopoulos, K. N., Allwood, J. W., Semple, R. K., Hebenstreit, D., Dunn, W. B., Tomlinson, J. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00947 · Cited by 215 · see citing works
Neuroendocrine control of the onset of puberty
Plant, T. M. (2015) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2015.04.002 · Cited by 213 · see citing works
Gan, S. D., & Graber, E. (2013) · Dermatologic Surgery · doi:10.1111/dsu.12116 · Cited by 211 · see citing works
Ovarian Follicular Theca Cell Recruitment, Differentiation, and Impact on Fertility: 2017 Update
Richards, J. S., Ren, Y. A., Candelaria, N. R., Adams, J. E., & Rajkovic, A. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00164 · Cited by 204 · see citing works
Sex, microbes, and polycystic ovary syndrome
Thackray, V. G. (2019) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.11.001 · Cited by 203 · see citing works
Age of menarche in a longitudinal US cohort
Biro, F. M., Pajak, A., Wolff, M. S., Pinney, S. M., Windham, G. C., Galvez, M. P., Greenspan, L. C., Kushi, L. H., & Teitelbaum, S. L. (2018) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2018.05.002 · Cited by 200 · see citing works
Kamrath, C., Hochberg, Z., Hartmann, M. F., Remer, T., & Wudy, S. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1997 · Cited by 191 · see citing works
Moore, A. M., Coolen, L. M., Porter, D. T., Goodman, R. L., & Lehman, M. N. (2018) · Endocrinology · doi:10.1210/en.2018-00389 · Cited by 190 · see citing works
Congenital Adrenal Hyperplasia
Witchel, S. F. (2017) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2017.04.001 · Cited by 187 · see citing works
Self-citationLifestyle Modification Programs in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis
Domecq, J. P., Prutsky, G., Mullan, R. J., Hazem, A., Sundaresh, V., Elamin, M. B., Phung, O. J., Wang, A., Hoeger, K., Pasquali, R., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2385 · Cited by 184 · see citing works
Understanding androgen action in adipose tissue
O’Reilly, M. W., House, P. J., & Tomlinson., J. W. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.04.008 · Cited by 180 · see citing works
Apter, D. L., Bützow, T. L., Laughlin, G. A., & YEN, S. S. C. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.1.8027216 · Cited by 177 · see citing works
Abbott, D. H., Tarantal, A. F., & Dumesic, D. A. (2009) · American Journal of Primatology · doi:10.1002/ajp.20679 · Cited by 177 · see citing works
Anderson, R. A., McLaughlin, M., Wallace, W. H. B., Albertini, D. F., & Telfer, E. E. (2014) · Human Reproduction · doi:10.1093/humrep/det388 · Cited by 176 · see citing works
Lizneva, D., Kirubakaran, R., Mykhalchenko, K., Suturina, L., Chernukha, G., Diamond, M. P., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.07.1121 · Cited by 171 · see citing works
Sharpton, S. R., Ajmera, V. H., & Loomba, R. S. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.08.065 · Cited by 170 · see citing works
Quality of life in adolescent girls with polycystic ovary syndrome
Trent, M. E., Rich, M., Austin, S. B., & Gordon, C. M. (2002) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.156.6.556 · Cited by 164 · see citing works
van Hooff, M. H. A. (2004) · Human Reproduction · doi:10.1093/humrep/deh079 · Cited by 162 · see citing works
Lass, N., Kleber, M., Winkel, K., Wunsch, R., & Reinehr, T. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1609 · Cited by 160 · see citing works
Casoni, F., Malone, S., Belle, M., Luzzati, F., Collier, F., Allet, C., Hrabovszky, E., Rasika, S., Prévot, V., Chédotal, A., et al. (2016) · Development · doi:10.1242/dev.139444 · Cited by 157 · see citing works
Moller, D. E., & Flier, J. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812083192306 · Cited by 154 · see citing works
Legro, R. S., Lin, H. M., Demers, L. M., & Lloyd, T. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6423 · Cited by 154 · see citing works
Is foetal hyperexposure to androgens a cause of PCOS?
Filippou, P., & Homburg, R. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx013 · Cited by 152 · see citing works
Pretorius, E., Africander, D. J., Vlok, M., Perkins, M. S., Quanson, J., & Storbeck, K.-H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0159867 · Cited by 148 · see citing works
Trent, M., Austin, S. B., Rich, M., & Gordon, C. M. (2005) · Ambulatory Pediatrics · doi:10.1367/a04-130r.1 · Cited by 147 · see citing works
Congenital Adrenal Hyperplasia
Witchel, S. F., & Azziz, R. (2011) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2010.10.001 · Cited by 147 · see citing works
Self-citationWolf, J. E., Shander, D., Huber, F., Jackson, J., Lin, C., Mathes, B. M., Schrode, K. B., & the Eflornithine HCl Study Group (2006) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2006.03079.x · Cited by 145 · see citing works
Barrett, E. S., Hoeger, K. M., Sathyanarayana, S., Abbott, D. H., Redmon, J. B., Nguyen, R. H. N., & Swan, S. H. (2018) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174417001118 · Cited by 145 · see citing works
Birch, R. A., Padmanabhan, V., Foster, D. L., Unsworth, W. P., & Robinson, J. E. (2003) · Endocrinology · doi:10.1210/en.2002-220965 · Cited by 144 · see citing works
A new dawn for androgens: novel lessons from 11-oxygenated C19 steroids
Pretorius, E., Arlt, W., & Storbeck, K.-H. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.014 · Cited by 142 · see citing works
Fertility Concerns and Sexual Behavior in Adolescent Girls with Polycystic Ovary Syndrome
Trent, M., Rich, M., Austin, S. B., & Gordon, C. M. (2003) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/s1083-3188(02)00205-x · Cited by 138 · see citing works
Mastorakos, G., Koliopoulos, C., & Creatsas, G. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)02993-x · Cited by 137 · see citing works
Epigenetic and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary Syndrome
Kokosar, M., Benrick, A., Perfilyev, A., Fornes, R., Nilsson, E., Maliqueo, M., Behre, C. J., Sazonova, A., Ohlsson, C., Ling, C., et al. (2016) · Scientific Reports · doi:10.1038/srep22883 · Cited by 137 · see citing works
Armengaud, J.-B., Charkaluk, M.-L., Trivin, C., Tardy, V., Bréart, G., Brauner, R., & Chalumeau, M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0314 · Cited by 135 · see citing works
George, J. T., Kakkar, R. K., Marshall, J., Scott, M. L., Finkelman, R. D., Ho, T. W., Veldhuis, J. D., Skorupskaite, K., Anderson, R. A., McIntosh, S., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1202 · Cited by 131 · see citing works
Cosma, M., Swiglo, B. A., Flynn, D. N., Kurtz, D. M., LaBella, M. L., Mullan, R. J., Elamin, M. B., Erwin, P. J., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2429 · Cited by 129 · see citing works
A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome
Clayton, W. J., Lipton, M., Elford, J., Rustin, M., & Sherr, L. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06426.x · Cited by 127 · see citing works
Randomized Placebo-Controlled Trial of Metformin for Adolescents With Polycystic Ovary Syndrome
Bridger, T., MacDonald, S., Baltzer, F., & Rodd, C. (2006) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.160.3.241 · Cited by 126 · see citing works
Bird, S. T., Hartzema, A. G., Brophy, J. M., Etminan, M., & Delaney, J. A. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.120677 · Cited by 126 · see citing works
Health-related quality of life among adolescents with polycystic ovary syndrome
Jones, G. L., Hall, J. M., Lashen, H. L., Balen, A. H., & Ledger, W. L. (2011) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1111/j.1552-6909.2011.01279.x · Cited by 124 · see citing works
Pall, M., Azziz, R., Beires, J., & Pignatelli, D. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.06.025 · Cited by 123 · see citing works
Rapid Maturation of the Reproductive Axis during Perimenarche Independent of Body Composition
Legro, R. S. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.1021 · Cited by 120 · see citing works
Domecq, J. P., Prutsky, G., Mullan, R. J., Sundaresh, V., Wang, A. T., Erwin, P. J., Welt, C., Ehrmann, D., Montori, V. M., & Murad, M. H. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2374 · Cited by 115 · see citing works
Polycystic ovarian morphology in postmenarchal adolescents
Codner, E., Villarroel, C., Eyzaguirre, F. C., López, P., Merino, P. M., Pérez-Bravo, F., Iñiguez, G., & Cassorla, F. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.06.015 · Cited by 113 · see citing works
Harlow, C. R., Shaw, H. J., Hillier, S. G., & Hodges, J. K. (1988) · Endocrinology · doi:10.1210/endo-122-6-2780 · Cited by 112 · see citing works
The prognosis for adolescents with menstrual abnormalities
Southam, A. L., & Richart, R. M. (1966) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(66)90398-x · Cited by 111 · see citing works
Laser and photoepilation for unwanted hair growth
Hædersdal, M., & Gøtzsche, P. C. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004684.pub2 · Cited by 110 · see citing works
Franks, S., & Hardy, K. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00452 · Cited by 109 · see citing works
Koivuaho, E., Laru, J., Ojaniemi, M., Puukka, K. S., Kettunen, J., Tapanainen, J. S., Franks, S., Järvelin, M., Morin-Papunen, L. C., Sebert, S. P., et al. (2019) · International Journal of Obesity · doi:10.1038/s41366-019-0318-z · Cited by 105 · see citing works
Rofey, D. L., Szigethy, E. M., Noll, R. B., Dahl, R. E., lobst, E., & Arslanian, S. A. (2008) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsn057 · Cited by 104 · see citing works
Ibáñez, L., Ong, K., Ferrer, A., Amin, R., Dunger, D., & de Zegher, F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-022002 · Cited by 100 · see citing works
Ontogeny and reversal of brain circuit abnormalities in a preclinical model of PCOS
Silva, M. S. B., Prescott, M., & Campbell, R. E. (2018) · JCI Insight · doi:10.1172/jci.insight.99405 · Cited by 100 · see citing works
Selective insulin action on skin, ovary, and heart in insulin-resistant states
Geffner, M. E., & Golde, D. W. (1988) · Diabetes Care · doi:10.2337/diacare.11.6.500 · Cited by 97 · cited 1× · see citing works
“This leads to the paradox of insulin signaling in PCOS; liver, skeletal muscle, and adipose tissue exhibit IR, whereas steroid-producing tissues and the pituitary retain insulin sensitivity [71, 72].”
BackgroundNilsson, E., Benrick, A., Kokosar, M., Krook, A., Lindgren, E., Källman, T., Martis, M. M., Højlund, K., Ling, C., & Stener-Victorin, E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00935 · Cited by 93 · see citing works
Clinical expression of polycystic ovary syndrome in adolescent girls
Sultan, C., & Paris, F. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.04.015 · Cited by 92 · see citing works
Overnutrition, Ectopic Lipid and the Metabolic Syndrome
Grundy, S. M. (2016) · Journal of Investigative Medicine · doi:10.1136/jim-2016-000155 · Cited by 92 · see citing works
Dapas, M., Sisk, R. K., Legro, R. S., Urbanek, M., Dunaif, A. E., & Hayes, M. G. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02496 · Cited by 92 · see citing works
Adipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome
Dumesic, D. A., Phan, J. D., Leung, K. L., Grogan, T. R., Ding, X., Li, X., Hoyos, L. R., Abbott, D. H., & Chazenbalk, G. D. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02086 · Cited by 92 · see citing works
Metformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis
Al Khalifah, R. A., Florez, I. D., Dennis, B., Thabane, L., & Bassilious, E. (2016) · PEDIATRICS · doi:10.1542/peds.2015-4089 · Cited by 91 · see citing works
Allen, H. F., Mazzoni, C., Heptulla, R. A., Murray, M. A., Miller, N., Koenigs, L., & Reiter, E. O. (2005) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2005.18.8.761 · Cited by 90 · see citing works
Xu, J., Bishop, C. V., Lawson, M. S., Park, B. S., & Xu, F. (2016) · Human Reproduction · doi:10.1093/humrep/dew100 · Cited by 90 · see citing works
Kisspeptin and LH pulsatile temporal coupling in PCOS patients
Katulski, K., Podfigurna, A., Czyzyk, A., Męczekalski, B., & Genazzani, A. D. (2018) · Endocrine · doi:10.1007/s12020-018-1609-1 · Cited by 89 · see citing works
Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis
Li, L., Feng, Q., Ye, M., He, Y., Yao, A., & Shi, K. (2017) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2017.1318840 · Cited by 85 · see citing works
Role of exercise training in polycystic ovary syndrome: a systematic review and meta-analysis
Benham, J. L., Yamamoto, J. M., Friedenreich, C. M., Rabi, D. M., & Sigal, R. J. (2018) · Clinical Obesity · doi:10.1111/cob.12258 · Cited by 85 · see citing works
The “backdoor pathway” of androgen synthesis in human male sexual development
Miller, W. L., & Auchus, R. J. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000198 · Cited by 84 · see citing works
Effect of weight loss on menstrual function in adolescents with polycystic ovary syndrome
Ornstein, R. M., Copperman, N. M., & Jacobson, M. S. (2011) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2011.01.002 · Cited by 82 · see citing works
Cree-Green, M., Rahat, H., Newcomer, B. R., Bergman, B. C., Brown, M. S., Coe, G. V., Newnes, L., Garcia-Reyes, Y., Bacon, S., Thurston, J. E., et al. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00192 · Cited by 82 · see citing works
Treatment options for hirsutism: a systematic review and network meta-analysis
Barrionuevo, P., Nabhan, M., Altayar, O., Wang, Z., Erwin, P. J., Asi, N., Martin, K. A., & Murad, M. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02052 · Cited by 82 · cited 2× · see citing works
“Meta-analyses including larger number of RCTs in women with PCOS showed limited or no benefit of insulin sensitizers on hirsutism [185, 186].”
BackgroundRecommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): An update
Trapp, C. M., & Oberfield, S. E. (2011) · Steroids · doi:10.1016/j.steroids.2011.12.009 · Cited by 81 · see citing works
Self-citationClinical significance of 11-oxygenated androgens
Turcu, A. F., & Auchus, R. J. (2017) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000334 · Cited by 80 · see citing works
Kawwass, J. F., Sanders, K. M., Loucks, T. L., Rohan, L. C., & Berga, S. L. (2017) · Human Reproduction · doi:10.1093/humrep/dex086 · Cited by 79 · see citing works
Kristensen, S. G., Mamsen, L. S., Jeppesen, J. V., Bøtkjær, J. A., Pors, S. E., Borgbo, T., Ernst, E., Macklon, K. T., & Andersen, C. Y. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00376 · Cited by 79 · see citing works
Neuroanatomical Framework of the Metabolic Control of Reproduction
Hill, J. W., & Elias, C. F. (2018) · Physiological Reviews · doi:10.1152/physrev.00033.2017 · Cited by 79 · see citing works
Kaczmarek, C., Haller, D. M., & Yaron, M. (2016) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2016.05.006 · Cited by 78 · see citing works
Marti, N., Galván, J. A., Pandey, A. V., Trippel, M., Tapia, C., Müller, M., Perren, A., & Flück, C. E. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.07.029 · Cited by 76 · see citing works
Berg, T., Silveira, M. A., & Moenter, S. M. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2304-17.2018 · Cited by 76 · see citing works
The Emerging Role of Epigenetics in the Regulation of Female Puberty
Lomniczi, A., & Ojeda, S. R. (2015) · Endocrine development · doi:10.1159/000438840 · Cited by 74 · see citing works
Marzouk, T. M., & Sayed Ahmed, W. A. (2015) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2015.01.002 · Cited by 73 · see citing works
Central obesity, faster maturation, and “PCOS” in girls
de Zegher, F., López-Bermejo, A., & Ibáñez, L. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.09.005 · Cited by 73 · see citing works
Hirsutism: an evidence-based treatment update
Somani, N., & Turvy, D. (2014) · American Journal of Clinical Dermatology · doi:10.1007/s40257-014-0078-4 · Cited by 69 · see citing works
Kyriakopoulou, L., Yazdanpanah, M., Colantonio, D. A., Chan, M. K., Daly, C. H., & Adeli, K. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.01.002 · Cited by 68 · see citing works
Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood
Abbott, D. H., & Bacha, F. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.05.023 · Cited by 67 · see citing works
Harris-Glocker, M., Davidson, K., Kochman, L., Guzick, D., & Hoeger, K. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.08.006 · Cited by 66 · see citing works
Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys
Abbott, D. H., Rayome, B. H., Dumesic, D. A., Lewis, K. C., Edwards, A. K., Wallen, K., Wilson, M. E., Appt, S. E., & Levine, J. E. (2017) · Human Reproduction · doi:10.1093/humrep/dex036 · Cited by 66 · see citing works
Reproductive tissues maintain insulin sensitivity in diet-induced obesity
Wu, S., Divall, S., Wondisford, F., & Wolfe, A. (2012) · Diabetes · doi:10.2337/db11-0956 · Cited by 65 · see citing works
Electrolysis and thermolysis for permanent hair removal
Wagner, R. F., Tornich, J. M., & Grande, D. J. (1985) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(85)70062-x · Cited by 62 · see citing works
Keller, E., Chazenbalk, G. D., Aguilera, P., Madrigal, V., Grogan, T., Elashoff, D., Dumesic, D. A., & Abbott, D. H. (2014) · Endocrinology · doi:10.1210/en.2014-1050 · Cited by 60 · see citing works
Menstrual patterns in the first gynecological year: a systematic review
Gunn, H. M., Tsai, M.-C., McRae, A., & Steinbeck, K. S. (2018) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2018.07.009 · Cited by 60 · see citing works
Nidhi, R., Padmalatha, V., Nagarathna, R., & Amritanshu, R. (2012) · International Journal of Yoga · doi:10.4103/0973-6131.98223 · Cited by 57 · see citing works
Ladson, G., Dodson, W. C., Sweet, S. D., Archibong, A. E., Kunselman, A. R., Demers, L. M., Lee, P. A., Williams, N. I., Coney, P., & Legro, R. S. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.05.048 · Cited by 56 · see citing works
Hyperinsulinaemic androgen excess in adolescent girls
Ibáñez, L., Ong, K. K., López-Bermejo, A., Dunger, D. B., & de Zegher, F. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.58 · Cited by 56 · see citing works
Insulin: the other anabolic hormone of puberty
Caprio, S. (1999) · Acta Paediatrica · doi:10.1111/j.1651-2227.1999.tb14410.x · Cited by 55 · see citing works
Kim, J. Y., Tfayli, H., Michaliszyn, S. F., & Arslanian, S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01958 · Cited by 55 · see citing works
Healthy post-menarchal adolescent girls demonstrate multi-level reproductive axis immaturity
Sun, B. Z., Kangarloo, T., Adams, J. M., Sluss, P. M., Welt, C. K., Chandler, D. W., Zava, D. T., McGrath, J. A., Umbach, D. M., Hall, J. E., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00595 · Cited by 55 · see citing works
Anti-Müllerian hormone in obese adolescent girls with polycystic ovary syndrome
Kim, J. Y., Tfayli, H., Michaliszyn, S. F., Lee, S., Nasr, A., & Arslanian, S. (2017) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2016.10.015 · Cited by 54 · see citing works
Xu, J., Xu, F., Lawson, M. S., Tkachenko, O. Y., Ting, A. Y., Kahl, C. A., Park, B. S., Stouffer, R. L., & Bishop, C. V. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox181 · Cited by 54 · see citing works
Mindfulness‐Based Stress Reduction in Women with Overweight or Obesity: A Randomized Clinical Trial
Raja‐Khan, N., Agito, K., Shah, J., Stetter, C. M., Gustafson, T. S., Socolow, H., Kunselman, A. R., Reibel, D. K., & Legro, R. S. (2017) · Obesity · doi:10.1002/oby.21910 · Cited by 53 · see citing works
The effect of eflornithine 13.9% cream on the bother and discomfort due to hirsutism*
Jackson, J., Jaime, J., Caro, G., Garfield, F. B., Huber, F., Zhou, W., Lin, C., Shander, D., Schrode, K. B., & the Eflornithine HCl Study Group (2007) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2007.03270.x · Cited by 51 · see citing works
Ibáñez, L., del Río, L., Díaz, M., Sebastiani, G., Pozo, Ó. J., López‐Bermejo, A., & de Zegher, F. (2017) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2017.04.010 · Cited by 51 · see citing works
A randomized pilot study of dietary treatments for polycystic ovary syndrome in adolescents
Wong, J. M. W., Gallagher, M., Gooding, H., Feldman, H. A., Gordon, C. M., Ludwig, D. S., & Ebbeling, C. B. (2016) · Pediatric Obesity · doi:10.1111/ijpo.12047 · Cited by 50 · cited 1× · see citing works
“low-fat diets during 6 months improved weight with no difference between diets [168].”
BackgroundSopher, A. B., Grigoriev, G., Laura, D., Cameo, T., Lerner, J. P., Chang, R. J., McMahon, D. J., & Oberfield, S. E. (2014) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0128 · Cited by 49 · see citing works
Self-citationTHERAPY OF ENDOCRINE DISEASE: Treatment of hirsutism in the polycystic ovary syndrome
Pasquali, R., & Gambineri, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0585 · Cited by 49 · see citing works
de Zegher, F., Reinehr, T., Malpique, R., Darendeliler, F., López‐Bermejo, A., & Ibáñez, L. (2017) · Obesity · doi:10.1002/oby.21935 · Cited by 49 · see citing works
Polycystic ovaries in female-to-male transsexuals.
Pache, T. D., & Fauser, B. C. J. M. (1993) · PubMed · Cited by 47 · see citing works
Peña, A. S., Doherty, D. A., Atkinson, H. C., Hickey, M., Norman, R. J., & Hart, R. (2018) · Archives of Disease in Childhood · doi:10.1136/archdischild-2017-312968 · Cited by 47 · see citing works
Self-citationMohamed-Hussein, Z.-A., & Harun, S. (2009) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-6-18 · Cited by 46 · see citing works
Dhayat, N. A., Marti, N., Kollmann, Z., Troendle, A., Bally, L., Escher, G., Groessl, M., Ackermann, D., Ponte, B., Pruijm, M. T., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203903 · Cited by 46 · see citing works
Anti-müllerian hormone in the pathophysiology and diagnosis of polycystic ovarian syndrome
Dumont, A., Robin, G., & Dewailly, D. (2018) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000445 · Cited by 45 · see citing works
Evolutionary determinants of polycystic ovary syndrome: part 2
Fessler, D. M. T., Natterson-Horowitz, B., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.016 · Cited by 44 · see citing works
Are young adult women with polycystic ovary syndrome slipping through the healthcare cracks?
Dokras, A., & Witchel, S. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4190 · Cited by 43 · see citing works
Self-citationOvarian and extra-ovarian mediators in the development of polycystic ovary syndrome
Puttabyatappa, M., & Padmanabhan, V. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0079 · Cited by 43 · see citing works
Thaysen‐Petersen, D., Bjerring, P., Dierickx, C. C., Nash, J. F., Town, G., & Hædersdal, M. (2011) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04353.x · Cited by 42 · see citing works
Abnormal infant islet morphology precedes insulin resistance in PCOS-like monkeys
Nicol, L. E., O’Brien, T. D., Dumesic, D. A., Grogan, T., Tarantal, A. F., & Abbott, D. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106527 · Cited by 41 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- Johnson T , KaplanL, OuyangP, RizzaP. National Institutes of Health Evidence-Based Methodology Workshop on Polycystic Ovary Syndrome. NIH EbMW Reports. Bethesda, MD: National Institutes of Health, 2012;1:1–14. Available at: https://prevention.nih.gov/sites/default/files/2018-06/FinalReport.pdf. Accessed 17 February 2019.
- Goldenring, 1988, Getting into adolescents HEADS, Contemp Pediatr, 5, 75
Cited by
Sorted by citations
Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
Singh, S., Pal, N., Shubham, S., Sarma, D. K., Verma, V., Marotta, F., & Kumar, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041454 · Cited by 521 · see citing works
Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
Sadeghi, H. M., Adeli, I., Calina, D., Docea, A. O., Mousavi, T., Daniali, M., Nikfar, S., Tsatsakis, A., & Abdollahi, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020583 · Cited by 445 · see citing works
Dapas, M., Lin, F. T. J., Nadkarni, G. N., Sisk, R., Legro, R. S., Urbanek, M., Hayes, M. G., & Dunaif, A. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003132 · Cited by 297 · see citing works
Bednarz, K., Kowalczyk, K., Cwynar, M., Czapla, D., Czarkowski, W., Kmita, D., Nowak, A., & Madej, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084334 · Cited by 148 · see citing works
Ovarian and extra-ovarian mediators in the development of polycystic ovary syndrome
Puttabyatappa, M., & Padmanabhan, V. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0079 · Cited by 43 · see citing works
Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis
Yumiceba, V., López-Cortés, A., Pérez-Villa, A., Yumiseba, I., Guerrero, S., García-Cárdenas, J. M., Armendáriz-Castillo, I., Guevara-Ramírez, P., Leone, P. E., Zambrano, A. K., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.585130 · Cited by 40 · see citing works
Lin, S., Deng, Y., Huang, J., Li, M., Sooranna, S. R., Qin, M., & Tan, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-99622-4 · Cited by 35 · see citing works
- Authors
- Witchel, S. F., Oberfield, S. E., & Peña, A. S.
- Affiliations
- University of Pittsburgh (US)
- Morgan Stanley Children's Hospital (US)
- The University of Adelaide (AU)
- Corresponding author
- Witchel, Selma Feldman
- Venue
- Journal of the Endocrine Society
- Publisher
- The Endocrine Society
- Published
- 2019-06-14
- Volume
- 3
- Issue
- 8
- Pages
- 1545-1573
- ISSN
- 2472-1972 (ISSN-L)
- PMC
- PMC6676075
- OpenAlex
- W2949825098
- Semantic Scholar
- 816223b3ea8123d377e6d647d277d34a5897a1ba
- Cited by
- 653
- References
- 225
- Citations by year
- 2026: 74 · 2025: 101 · 2024: 134 · 2023: 140 · 2022: 100 · 2021: 63 · 2020: 37 · 2019: 3 · 2018: 1
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of the Endocrine Society (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc-nd)
- Funders
- Australian National Health and Medical Research Council Center (APP1078444)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
- Keywords
- polycystic ovary syndrome, adolescent girls, hyperandrogenism, anovulation, menstrual irregularity, PCOS diagnostic criteria, Rotterdam criteria, PCOS pathophysiology, lifestyle intervention, metformin, oral contraceptives, spironolactone, hirsutism, acne, PCOS comorbidities, transition to adult care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review